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INTRODUCTION 
Fetal growth restriction continues to be one of the major 
complications of pregnancy affecting 5-10%  of all gestation  .It is 
associated with increased morbidity and mortality in perinatal period 
and in infancy  .More over the adverse  consequences  of fetal growth 
restriction extend beyond early years into later  life .The concept of 
developmental programming pioneered by Prof. David  Barker & 
others has stimulated tremendous research into the origin of a 
spectrum of cardiovascular and metabolic disorders in adults .But the 
exact causes of fetal  growth restriction in utero still remains unclear. 
Antenatal fetal surveillance plays a major role in identifying fetuses at 
risk of   IUGR   to offer them close monitoring to prevent the perinatal 
mortality & morbidity & long term consequences. 
Deficiency in growth implies failure of the fetus to realise its 
genetically endowed growth potential .Determining the growth 
potential of an individual fetus however remains difficult. Many 
studies have produced normative gestational age specific birth weight 
standards that have been used to define   retrospectively    suboptimal 
fetal growth. Before the introduction of ultrasound, prospective 
measurement of fetal growth during pregnancy has been limited to 
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measuring uterine size and guessing fetal size by palpation. Over the 
last few decades,   ultra sonogram & Doppler has come into play a 
major role in evaluation of fetal growth in utero. 
DEFINITION; 
IUGR can be defined as a   condition   in which the fetus fails to 
achieve its genetic growth potential   and it is at   increased   risk   of  
perinatal morbidity and mortality. A fetus is considered growth 
restricted when ultrasonographically measured fetal dimensions 
particularly AC or EFW from multiple biometric measurements, 
below a certain gestational age specific threshold. The most 
commonly used threshold is 10th percentile.  This standard is arbitrary 
& it may lead to misdiagnosis of growth restriction. A more rigorous 
threshold such as 5th or 3rd percentile would be more specific but it is 
less sensitive. 
CLASSIFICATION OF IUGR; 
There are 3 types of IUGR based on time of onset & the 
pathological   process.
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TYPE 1 OR   SYMMETRIC OR INTRINSIC   IUGR: 
Accounts    for   20-30%  of  IUGR. 
Due to    growth   inhibition  early in pregnancy. 
All parameters like BPD/ HC/AC /EFW are below 10th 
percentile& they have normal ponderal index. 
Causes are mainly INFECTION IN UTERO (HERPES 
SIMPLEX, RUBELLA, CYTOMEGALO VIRUS, 
TOXOPLASMOSIS) Chromosomal disorders& congenital 
malformation. 
Any insult in early phase of fetal development (4-20 wks) result 
in reduced number of cells in the fetus & overall reduction in growth 
potential. 
These babies may not have immediate effect but they are at risk 
of long term complications like neurodevelopmental dysfunction. 
TYPE 2 OR ASYMMETRIC IUGR:   
Accounts  for 70-80%  of IUGR. 
Due to placental insufficiency resulting from maternal condition 
or placental pathology. 
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Onset  usually  after 28 weeks. 
In USG , BPD, HC remains normal, but AC& Ponderal index  
are low due to redistribution of blood flow from    periphery to Brain 
and Heart. 
These babies are at great risk of antepartum and intrapartum 
complications as well as neonatal morbidity and mortality. Moreover 
timely identification and interventions can reduce these complications. 
TYPE 3 OR INTERMEDIATE IUGR: 
Accounts for 5-10% of IUGR. 
Combination of Type 1& Type 2 IUGR. 
With this background this study has been conducted to know 
about the predictive value of placental volume that is measured 
antenatally by two dimensional ultrasound over the adverse prenatal 
outcome of the IUGR fetuses. 
  
5 
 
AIM OF THE STUDY: 
1 To estimate the placental volume using 2 dimensional 
ultrasound. 
2. To estimate the placental volume immediately following 
delivery. 
3. To compare the placental volume measured before delivery by 
ultrasound with that of measured after delivery. 
4. To compare the placental volume in IUGR and NORMAL 
pregnancy. 
5. To correlate the adverse perinatal outcome with placental 
volume in IUGR pregnancy. 
  
6 
 
REVIEW OF LITERATURE 
Fetal weight is determined by the genetic growth potential, the 
health of the fetus, the capacity of the mother to supply adequate 
substrate for growth and the ability of the placenta to transport the 
substrates to the fetus. Hence   placenta acts as a vector for all nutrient 
exchange between the mother and the fetus & it has principle 
influence  on the birth weight of the fetus. 
DIAGNOSIS OF IUGR: 
IUGR is suspected  in patients  with risk factors like 
preeclampsia, chronic renal disorders  vasculopathy ,infections  ,low 
pre pregnancy BMI  ,poor maternal wt gain. 
Determination of gestational age is the most important step in 
the diagnosis of IUGR. 
1.  Clinical method:  Serial measurement of symphysio fundal 
height & abdominal circumference are the most common 
clinical methods. Symphysio fundal  ht  increases by 1 cm 
/wk& it coincides with the gestational age between 18-30 wks. 
A lag in the fundal ht of 4 wks is suggestive of moderate 
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IUGR& lag of >6 wks is suggestive of severe IUGR. This 
method has low sensitivity when used alone. 
Both ACOG and RCOG   recommend this simple technique to 
identify abnormal growth. ACOG suggests that symphysio 
fundal height measurement at 32-Both ACOG and RCOG  
recommend this simple technique to identify abnormal growth. 
ACOG suggests that symphysio fundal height measurement at 
32-34 weeks has 70-85%  sensitivity and 96% specificity in 
detecting IUGR. Whereas RCOG suggest that it has 27% 
sensitivity and 88% specificity in detecting IUGR. 
Bakketeig et al (1984)1 compared the clinical method with 
sonographic study and concluded that detection rate of IUGR 
for these two groups was similar (25% for ultrasound and 11% 
for symphysiofundal height; RR 1.36, 95% CI 0.93-1.99) 
2. ULTRASONOGRAM:  There are several parameters used in 
diagnosis of IUGR. Among that AC has highest sensitivity and 
greatest negative predictive value  .An increase in AC less than 
10mm in 2 wks has 85% sensitivity and 74% specificity in 
detecting IUGR. Various age independent morphometric ratios 
like HC/AC,/ FL/AC   also been used in detection of IUGR. 
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Mckenna et al (2003)2 studied ultrasound examination of the 
patients consisting of Estimated fetal weight, Amniotic fluid 
index and placental grade at 30-32 weeks and 36-37 weeks and 
the clinical methods like symphysiofundal height alone. They 
reported that the prevalence of IUGR was significantly lower in 
ultrasound examination (7%)   than with clinical method (10%), 
(95% CI 0.50-0.89). 
3. Doppler velocimetry:   doppler has poor sensitivity in detecting   
IUGR.  But the doppler changes correlates well with the 
outcome of the fetus.  Changes in blood flow velocimetry of 
umbilical arteries is an early predictor of IUGR .Ductus venosus  
flow alteration is an accurate predictor of acidemia. 
In idiopathic IUGR where there are no obvious fetal / maternal 
causes, the placenta might hold the key to the etiology. Various 
authors recorded contradictory histological and morphological 
findings while comparing the placenta  of IUGR pregnancies to 
that of normal pregnancies.  
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ETIOLOGY OF IUGR: 
Numerous maternal,   fetal and placental disorders may interfere 
with normal mechanisms that regulate fetal growth resulting in IUGR. 
MATERNAL FACTORS: 
1. Maternal hypertensive disorders: 
Hypertensive disorders present in 30-40% 0f pregnancies 
complicated with IUGR. Pre eclampsia, chronic hypertension with or 
without pre eclampsia, autoimmune disorder nephropathy 
,pregestational  diabetes are associated with maternal vasculopathy 
may lead to fetal growth restriction. 
According to Odegard vattern/Nilsen et al   (2000)10, 
preeclampsia is associated with 4 fold increase of having IUGR 
babies(RR=4.2; 95% CI 2.2-8.0). 
The worse the severity and the earlier the onset of pre eclampsia 
the lower the birth weight.  Long,Abell ,Beisher (1980)11 reported that, 
the decrease in birth weight was 5% in mild pre eclampsia(95% CI 3-
6)& 12% with severe disease(95% CI 9-15) and it was  23% with 
early onset disease(95% CI 18-29).There is evidence that elevated 
diastolic blood pressure without proteinuria is associated with small 
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for gestational age but the risk is lower than that of proteinuric 
hypertension.According to Sibai (2002)12 there is variable increase in 
small for gestational age infants with mild chronic hypertension in 
pregnancy(8-15.5%). Proteinuria occurring in early pregnancy is 
associated with elevated risk of  fetal growth restriction(OR 2.8; 95% 
CI 1.6-5.0). 
Moreover maternal antihypertensive therapy fails to improve 
fetal growth and some beta blockers like Atenolol increases the risk of 
growth restriction. 
2. Maternal autoimmune disorders: 
Any maternal auto immune disorders  especially with vascular 
involvement are associated with adverse perinatal outcome. 
Patients with antiphospholipid antibody syndrome shows 
significant increase in stillbirth. 
SLE   in pregnancy is associated with 3 fold increase in fetal 
death when APA is positive than negative. 
In a prospective study by Yasudha,Takakuwa,Tokunaga et al 
(1995)13 the relative risk of growth restriction with positive APA  was 
6.22% (95% CI 2.43-16). 
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3. Thrombophilia: 
Controversy still remains in the association between IUGR and 
maternal Thrombophilia. Recent meta analysis of 10 case control 
studies by Howley/ Walker/ Rodger(2005)14 showed a significant 
association between IUGR and presence of factor v leiden 
mutation(OR 2.7; 95% CI 1.3-5.5)& prothrombin gene variant (OR 
2.5; 95% CI 1.3-5). The relationship between methylene tetra 
hydrofolate reductase mutation and IUGR still remains 
unsubstantiated. 
4. Maternal life style: 
Maternal use of various recreational drug & addictive 
substances is associated with IUGR. However causal relationship is 
difficult to establish often due to other associated confounding factors 
like malnutrition, multiple substance abuse ,stress and other lifestyle 
variables.  
Maternal smoking is associated with decrease in EFW due to 
the carbon monoxide which interferes with fetal oxygenation and the 
vasoconstrictive  property of nicotine/ kramer ms(1987)15. 
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Cliver et al (1995)16 noted in average birth weight reduction of 6% 
when  smoking was continued throughout gestation compared with 
only 1.7% when it was stopped after 1 st trimester and this effect was 
appeared to be dose dependent and also increased by other cofactors 
like hypertension. Cnattingius,Mills et al (1997)17 showed increased 
incidence of small for gestational  infant when smoking was 
associated with hypertension than not associated with it(40% vs 5%). 
Taking alcohol even 1 drink per day is associated  with IUGR  
and  low Apgar at birth(Windham et al 1995)18. 
Cocaine use in pregnancy is also associated with significant 
maternal and fetal effects including maternal stroke, cardiac 
arrhythmia, hypertension, placental abruption, fetal brain injury and 
still birth. 
5. Therapeutic agents:  
Antineoplastic agents, anticonvulsants such as phenytoin, Beta 
blockers and steroids are associated with IUGR. 
6. Malnutrition: 
The effect of maternal malnutrition on fetal  growth depends 
upon the severity of deprivation &  the period of gestation. 
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7. Environmental pollution: 
 Epidemiological investigations on the impact of environmental 
pollution on pregnancy outcome show significant but slight increase in 
the frequency of IUGR(Maisonet,Coree,Misra et al 2004)19. 
This effect was discernible even with relatively low 
concentration of gaseous pollutants such as So2 ,No2  ,CO, Ozone 
(Liu et al 2003)20. 
FETAL FACTORS: 
1. Aneuploidy: 
Fetal chromosomal anomalies are strongly associated with 
IUGR. About 7% of IUGR   is  attributable to aneuploidy. 
Early growth restriction is associated with increased odds of trisomy 
18& trisomy 13(Bagadosingh et al 1997)21. 
90% of trisomy 18  are associated with IUGR when compared 
to 30% in trisomy 21. 
Fetuses with aneuploidy are associated with increased incidence 
of fetal malformations leading to higher frequency of somatic 
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asymmetry, increased or decreased amniotic fluid volume and normal 
doppler indices of umbilical and/ or uterine artery.  
2. Genomic imprinting & uniparental disomy: 
UPD is inheritance of both homologs of a chromosome from a 
single parent. 
Several autosomal chromosomes and X-chromosomes   have 
been implicated  with UPD and are associated with IUGR. 
Maternal UPD of chromosome 16 is the one most commonly 
associated with IUGR. Abnormal imprinting results in abnormal 
phenotypes including fetal growth restriction and dysmorphic features. 
In Prader willi syndrome loss of function of imprinted genes on the 
paternal allele in 15q11-13 leads to growth restriction in utero and 
associated with other developmental problems. 
Maternal Uniparental disomy involving imprinted region in 
chromosome 7, clinically characterised by prenatal and postnatal 
growth deficits and dysmorphic features. 
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3. Fetal malformations: 
A  population based study conducted by CDC  demonstrated 
>22% of infants with congenital malformations are growth restricted 
with relative risk of 2.6(Khoury, Erickson 1998)22. 
Multiple malformations increases the risk of IUGR and the 
frequency was increased from 20% in infants with two defects to 60% 
in infants with 9 defects. The cardiac anomalies most commonly 
associated with small for gestation are Tetrology of Fallot, 
Endocardial cushion defects, Hypoplastic left heart, Pulmonary 
stenosis, ventricular septal defect not only heart disease , anencephaly 
and anterior abdominal wall defects also associated with growth 
restriction in the fetus. A single umbilical artery even in the absence of 
other malformation or aneuploidy may be associated with fetal growth 
restriction.  
4. Perinatal infections : 
5-10% of IUGR are attributable to viral or protozoan infection 
in utero. 
The viral infections most commonly associated with growth 
restriction are Rubella , Cytomegalovirus, Human immuno deficiency 
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virus and Varicella zoster. The early infection which leads to decrease 
in cell population may be the most frequently involved mechanism in 
growth restriction.                                                                             
Protozoal infections like Malaria and Toxoplasmosis can also 
lead to growth restriction of the fetus. In malaria the adverse effects 
include maternal anemia, prematurity and growth restriction. 
Bacterial infection usually not associated with growth 
restriction there is evidence suggest that subclinical infection and  
inflammation leading to chorioamnionitis may result in growth 
restriction. Offenbacher, Lieff et al (2001)23 suggest that maternal 
periodontal disease can lead to preterm and small for gestational births 
and it could be a modifiable etiology of IUGR.  
5. Multiple gestation: 
In multiple gestation the maternal system has to provide 
optimum environment for individual fetus to sustain fetal growth. 
Individual fetuses in multiple pregnancy shows different growth 
profile than that of singleton pregnancy. Guenwald (1966)24 
demonstrated the growth curves of singleton and twins were same 
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upto 30-32 weeks after which the growth of the twins lagged behind 
that of singleton. 
Small for gestational births are noted in 20% of dichorionic 
fetuses and 30% of the monochorionic fetuses. The aetiology for this 
is similar to that of singleton pregnancy and include hypertensive 
disorders , malformation, poor weight gain, low prepregnancy body 
mass index.  An additional factor in multiple pregnancy is discordant 
growth before 30 weeks is associated with twin to twin transfusion 
syndrome and high risk of perinatal mortality.    
PLACENTAL FACTORS: 
Placenta being the lifeline between mother and  the fetus has a 
critical role in IUGR. The role is however mediated by  anatomic, 
vascular, chromosomal & morphological abnormality. 
Abnormal placentation, placenta previa,  chronic villitis, 
placental infarcts, haemorrhagic endovasculitis ,placental 
haemangioma, chorioangiomas  are some of the placental conditions 
associated with IUGR. 
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COMPLICATIONS OF  IUGR: 
ANTENATAL: 
Antenatal and intrapartum  hypoxia ,acidosis are the most 
important and frequent complications of IUGR. According to Lin et 
al.,(1980)3 the incidence of non reassuring fetal heart rate pattern in 
electronic fetal  heart rate monitoring during labour is up to 40%. 
STILL BIRTH: 
Marana found (1980)4 that 20% of all stillborns show evidence 
of IUGR. Morrisen and Olsen(1985)5 found 26% of stillborn weighing 
<2.5 kgs  is associated with IUGR. 
OLIGOHYDROMNIOS: 
Chamberlein et al (1984)6 showed that the incidence of IUGR 
with normal amniotic fluid volume was <5% but when 
oligohydromnios  was  present it was up to 40%. 
INTRAPARTUM COMPLICATIONS: 
The incidence of intrapartum hypoxia and acidosis are high in 
IUGR.  The incidence of caesarean section is increased  due to 
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nonreassuring  fetal heart rate pattern in electronic fetal heart rate 
monitoring. 
EARLY NEONATAL COMPLICATIONS: 
Respiratory distress syndrome:  main cause of mortality and morbidity 
in IUGR. 
Meconium  aspiration syndrome  also a major cause of 
mortality and morbidity. 
persistent  fetal circulation due to perinatal hypoxia and acidosis. 
Intraventricular  bleeding and perinatal leukomalacia are the 
most frequent neurological complications of preterm IUGR. 
Neonatal  encephalopathy  is an essential component of cerebral 
palsy secondary to fetal asphyxia. 
Hypoglycaemic   episodes occur in 25% of term IUGR and 67% 
of preterm IUGR. 
Hypocalcaemia  can occur secondary to chronic hypoxia. 
 Hyper viscosity leading to necrotising enterocolitis, pulmonary 
infarcts, hyper bilirubinemia. 
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Hypothermia due inadequate subcutaneous fat. 
LONG TERM PROGNOSIS: 
Postnatal growth:  Hill(1978) 7    showed that 30% of babies will 
remain below 30th percentile for their age and only 10-20% will  be 
above  50th percentile. 
Cerebral palsy:   Follow-up  studies showed that intelligence ,motor 
skills, speech and reading abilities are affected in IUGR 
babies.(Robertson et al.,(1990)8; Kok et al (1998),)9. 
several studies showed incidence of chronic hypertension, abnormal 
lipid profile ,ischemic heart disease ,type 2 diabetes are increased in 
later life. 
Salafia (1997)31 proposed that not a single but several 
histological & morphological changes of placenta  resulted in IUGR. 
Though the contribution of placental changes  remained controversial , 
it was accepted that IUGR was associated with fetal hypoxia  resulting 
partially from alteration in growth & development of placental villi & 
their underlying vasculature ( Benrische, Kaufman 1995)32 
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PLACENTAL VASCULAR DEVELOPMENT IN NORMAL 
AND IUGR PREGNANCY: 
Maldevelopment of  uteroplacental & fetoplacental  circulatory 
system has been shown to be associated with fetal growth compromise 
and pre eclampsia. 
In the maternal placental circulation, a subset of trophoblasts 
invades the spiral endometrial arteries & remodel them into widely 
dilated uteroplacental arteries.   As a consequence, the uteroplacental 
flow impendence   progressively declined& the maternal blood flow 
through the intervillous space exponentially increases. 
The changes in the uteroplacental  arteries occur in 3 phases; 
Before trophoblastic   invasion, the arteries from both within and 
outside the implantation site show several changes including 
dilatation,  vacuolation  of endothelial  cells and disrupted  smooth 
muscle cells in the tunica media. 
In the next phase, the interstitial trophoblasts surround  the  
spiral arteries & induce fibrinoid deposition & other changes in the 
arterial media. 
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Finally, the trophoblasts invade the arteries  & are transformed 
into immensely dilated conduits devoid of vasoactive capability. 
These changes are more in the centre  of the placenta than in the 
periphery. 
FETOPLACENTAL ANGIOGENESIS & IUGR: 
Feto placental angiogenesis is a continuous   process starting 
soon after the implantation and evolving through pregnancy in 3 
phases; 
From post conception day 21-32, vasculogenesis   occurs in 
which capillary networks are formed providing foundation  for 
subsequent fetoplacental vascular & villous growth; 
From 32nd day to 24 wks of gestation, branching angiogenesis 
dominates  leading  to the formation of 10-16 generations of stem villi. 
               Beyond 24 wks , the expansion of the feto placental vascular 
system is mainly by non branching  angiogenesis characterised by 
elongation of the vessels rather than by branching.
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According to Krebs & colleagues (1996)25 and Todros & 
colleagues(1996)26, abnormal development of villous tree has been 
shown to be associated with early onset pre eclampsia & IUGR. 
 
PLACENTAL TRANSPORT MECHANISM & IUGR: 
The concept of placental insufficiency in IUGR is by deficient 
maternal to fetal  nutrient transport. 
Invitro  human  placental experiments show diminished activity 
& expression of placental transporters for essential amino acids  & 
ions in IUGR pregnancies (Cetin 2003)27. 
Deficiency in glucose transport mechanisms has been observed 
in preterm IUGR than in term IUGR placentas( Jansson, Yivar et al 
2002)28. 
ASSESMENT OF PLACENTAL GROWTH: 
There are so many standard placental growth parameters used in 
older birth cohorts are still in use. 
1. Placental disk shape: Normal placenta is round to oval in shape. 
Naye(1992)29 concluded that irregular placental shape  was 
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associated with parent & sibling seizure disorder and adverse 
pregnancy outcome like preterm birth/ neurological abnormality 
@ 7yrs. 
2.  Location of umbilical cord  insertion from the edge of the 
placenta: Cord malpositioning  may be due to abnormal growth 
of placenta towards  one side or abnormal positioning of the 
embryo. Nayes analysis suggested   that marginal cord  insertion 
was   associated with  twinning & major  fetal malformation & 
also with maternal acetonuria  during 1st trimester, Diabetes, 
IUGR. 
3. Placental disk diameter: It determines the maximum number of 
spiral arteries that are involved in uteroplacental unit. 
4. Disk thickness:  Most of the placental growth in 3rd trimester 
is by increase in thickness   which reflects the extent  of  
nutrient exchange surface of the placenta essential for the 
successful and  adequate fetal growth. Increased disk thickness  
decreases the placental efficiency  and so abnormally  thick 
placenta also  associated  with adverse pregnancy  
outcome(Raio,Ghazzi et al 2004)30. 
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5. Feto placental weight ratio. 
Only few workers  had  performed histomorphometric studies of 
the placenta associated with IUGR. Aherne & Dunnill(1996)33 dealt 
with quantitative aspects of placental structure .They observed that 
IUGR infants born at term had placenta with reduced mean 
volume(350 ml). The mean values for volume proportions of 
chorionic villi did not differ from control. 
 In early 80s Geirsson et al34 studied the use of measuring 
placental volumes in normal & abnormal pregnancies.  
In 1984 the first fetal volumes acquired by USG were 
constructed by Brinkley et al. Since the development of 3 dimensional 
USG imaging assisted by computer technology it is possible to 
measure and calculate fetal & placental volume quickly & accurately 
.Measuring & monitoring fetal and  placental volume at different 
gestational ages may improve our understanding about physiological 
and pathophysiological  mechanisms in fetal  & placental  growth. 
Fetal and placental volumes have been used in screening of fetuses 
with chromosomal anomalies/ IUGR/preeclampsia. There are reports 
in literatures that increase in placental volume preceding pre 
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eclampsia & decrease in placental volume preceding IUGR & 
decrease in fetal volume in fetuses with chromosomal anomaly. 
Wallace et al(2004)35 concluded that it is the small size of the 
placenta per se rather than alteration in the nutrient metabolism or 
transferring capacity has  a major limitation to fetal growth. 
Thame & colleagues (2005)36 have recently shown that the 
effects of maternal anthropometry on birth weight are likely to be 
mediated by effects of maternal anthropometry on placental volume. 
These effects operate early in pregnancy and alter both the absolute 
placental volume at 14 wks and rate of growth of placenta  between 17 
& 20 wks. 
Clapp & colleagues (2004)37 identified a robust relationship 
among  the rate of increase in individual maternal  IGF 1 levels after 
16 wks , placental mass & neonatal fat mass. 
Laviola, Perrini et al (2005)38 showed an abnormal  IGF signalling has 
been linked to human IUGR. 
Lepereq & colleagues  (2003)39 showed Leptin  may also 
contribute to this complex  communication between mother, fetus & 
placenta may be an early Response Element to placental dysfunction. 
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I.Cetin G, Alvino (2009)40 showed that IUGR correlates with a 
specific placental phenotype associated with defects in placental 
transport function that lead to fetal under nutrition. Both placental 
transport and metabolism may be affected thus modifying the 
nutritional  supply to the fetus. In pregnancy, nutrient concentration 
can be measured at the time of delivery or at the time of cordocentesis.  
In IUGR the placental supply of aminoacid is significantly reduced 
independently from the severity of growth restriction and from the 
presence of hypoxia.  Moreover maternal and fetal gradient of glucose 
are increased  in severe IUGR.This summarizes the current knowledge 
about placental metabolism and transport in IUGR pregnancies and 
the relationship with the severity of the disease. 
I Cetin,J M , Foidart, M  Miazzo (2004)41 
IUGR are associated with increased perinatal mortality and 
morbidity as well as cardiovascular disease and glucose intolerance in 
adult life. A number of genetic to metabolic , vascular , coagulative, 
autoimmune as well as infectious can influence fetal growth by 
damaging the placenta. Strict definition of IUGR and its severity are 
needed in order to eventually distinguish among different phenotypes 
such as gestational age at onset, degree of growth restriction and 
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presence of hypoxia. New existing findings on the genomic imprinting 
defects potentially associated with IUGR. 
Marcus Rijken, Williams E Moroski,Suporn Kiricharo(2012)42 
studied the effect of malaria on placental volume measured using 3 
dimensional ultrasound. Malarial parasites and histopathological 
changes in placenta are associated with reduction in birth weight 
principally due to IUGR. They studied the feasibility of measuring 
early pregnancy volume by 3 dimensional ultrasound in malaria 
endemic area. They found that small placental volume in second 
trimester may be an indicator of IUGR and placental insufficiency.   
Imdal,Aamer,Yakob, Mohammad Yawar(2011)43 
Studied the correlation between stillbirth and IUGR.Early 
detection and management of IUGR can lead to reduced related 
morbidity and mortality. They reviewed the effectiveness of fetal 
movement count, doppler for detection and surveillance of high risk 
pregnancy and the effect of this in the prevention of stillbirth.They 
also reviewed the effect of Body mass index screening ,symphysio 
fundal height, target ultrasound in detection and triage of IUGR in the 
community.Finally they concluded that there is insufficient evidence 
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to recommend in favour or against fetal movement count for routein 
use of testing fetal wellbeing.Arterial doppler analysis and appropriate 
intervention is associated with 29% reduction in perinatal mortality 
(95% CI 2-48). Expert opinion suggest that detection and management 
of IUGR with the help of maternal Body mass index, symphysio 
fundal height., targeted ultrasound could be effective in reducing 
IUGR related stillbirth by 20%. 
Hata T,Tanaka H, Noguchi J, Hata K (2011)44  
Studied the effectiveness of conventional 2 dimensional 
ultrasound in evaluation of placenta during pregnancy.This 2 
dimensional ultrasound evaluation includes morphology, anatomy, 
location, implantation, anomaly, size, power and pulsed doppler 
sonographic assessment of placenta. The introduction of 3 
dimensional  ultrasonography would facilitate the novel assessment of 
the placenta such as surface rendered imaging and volume assessment. 
The novel technique may assist in the evaluation of fetoplacental 
function and offer potential advantages relative to conventional 2 
dimensional sonographic measurement.  
Hafner,philipp schuchter (2002)45  
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Suggested that prognostic influence could be shown   for 
placental volume , gestational age at the time of measurement and 
maternal weight at the time of registration. 
Ferrazi,Bulfamante, Mezzopane (1998)46  
Stated that the presence of abnormal doppler velocimetry of the 
uterine arteries in pregnancies with IUGR  may be in fact an important 
indicator of hypoxic or ischemic placental lesions .This abnormal 
velocimetry is independent of the maternal blood pressure status. 
Noguchi J,Tanaka H, Hata T (2009)47 
Investigated  placental vascular sonobiopsy using 3 dimensional 
ultrasound in normal and IUGR pregnancies. Placental vascular 
sonobiopsy using 3 dimensional power doppler ultrasound with 
VOCAL imaging was performed in 208 normal fetuses between 12-40 
weeks and 13 pregnancies with IUGR between 22-39 weeks gestation. 
3dimensional power doppler indices related to placental 
vascularisation were calculated. They found that placental vascular 
sonography may provide new information in the assessment of 
placental vascularisation in normal and IUGR pregnancies and 
placental perfusion is reduced in IUGR compared to normal. 
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Jang,DongGyu, Jo,Yun Sung, Lee(2011)48 
Evaluated perinatal outcome and maternal characteristics in 
IUGR with absent or reversal of end diastolic flow (AEDV)  
independent of oligohydromnios, gestational age, and maternal 
factors. They compared 57 normal and 19 patients with Absent end 
diastolic flow. They found that gestational age was lower in AEDV 
group when compared to normal group.The birthweight and platelet 
count were lower in AEDV group and serum SGOT , non reassuring 
CTG were higher independent of gestational age. Perinatal outcome 
such as Apgar at 1 minute <4 ,use of ventilator , admission to NICU, 
respiratory disease, neurological disease, neonatal sepsis, anaemia, 
thrombocytopenia, and neonatal mortality  were statistically less 
favourable in AEDV group. 
Hafner et al (1998) revealed that the measurement of placental 
volume between 16 & 23 wks of gestation has a sensitivity   of 53.5% 
for prediction of IUGR and neonatal birth wt below 10th percentile. 
HAFNER, PHILIPP, SCHUCHTER(2002)49 
Conducted prospective study in 382 women with singleton  
uncomplicated pregnancies at 16-23 wks to investigate the value of 
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2nd trimester  3-dimensional sonographic placental volume 
measurement to predict infants who are <10th percentile for birth 
weight .They inferred  that placental volume estimation in predicting 
IUGR had 82.5% sensitivity & 52.5% specificity and prognostic 
influence could be shown for placental volume(p<0.0001), gestational 
age at the time of measurement(p=0.0002) & maternal weight at the 
time of registration(p=0.0025).They concluded that 3 -dimensional 
sonographic measurement of placental volume alone is not 
satisfactory technique of predicting IUGR. 
GIUSEPPE, RIZZO, ALESSANDRA CAPPONI(2008)50 
Compared the efficacy of uterine artery doppler velocimetry & 
3-dimensional sonographic measurement of placental volume,  alone  
or in combination at 11-14 wks of gestation as a predictor for 
development of pre eclampsia. It was a prospective study involving 
348 women who were scheduled for a routein  prenatal ultrasonogram 
at 11-14 wks & the mean pulsatility index of uterine artery was 
calculated  and, placental was volume measured using 3-dimensional 
sonogram. The outcome considered were development of pre 
eclampsia & pre eclampsia requiring delivery < 32 wks. On 
observation they found that  the placental volume was significantly 
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lower in women who developed pre eclampsia later(p<0.003).There 
was no relationship between  placental volume & mean uterine artery 
pulsatility index(p=0.327).Both showed similar sensitivities in 
predicting pre eclampsia(60% vs 66%) & pre eclampsia requiring 
delivery before 32 wks (66.7% vs 67%). The combination  of both 
gave better results with sensitivity of 68.7% in predicting pre 
eclampsia& 83.3% for requiring delivery <32 wks.So they concluded 
that the combination of abnormal uterine artery doppler & low 
placental volume at 11-14 wks achieves better results than done alone. 
CHRISTIANE KREBS, LENA.M MACERA, RUDOLF LEISSSER 
(1998)51 
They evaluated the structure of placental terminal villi & their 
capillaries in pregnancies complicated by IUGR with absent end 
diastolic flow in umbilical artery. 10 placental specimens were taken 
from IUGR pregnancies and from well matched  normal pregnancies 
as control.The structure and dimensions of 20 terminal capillary loops 
were determined by electron microscopic examination & their 
appearance were correlated with peripheral villi.The result observed 
was in the IUGR cases the capillary loops were sparse in no, & 
significantly longer than control cases(218  vs  137µm).They also 
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exhibited fewer branches ( 4/loop vs 6/loop, p<0.06) and the majority 
of the loops were uncoiled ( 79% vs 18% ,p<0.06).From this they 
concluded that the terminal villous compartment of the placenta 
appeared to be maldeveloped in IUGR with absent end diastolic flow 
in umbilical artery before delivery. These findings were consistent 
with increased fetoplacental vascular impedence at capillary level & it 
might account for the impaired gas and nutrient   transfer across  the 
placenta. 
THAME, OSMONDE,WIKS52 
They investigated the ability of 2nd trimester placental volume   
measurement by ultrasonogram  in predicting the birth weight of the 
fetus. They selected 512 women and measured fetal anthropometry & 
placental volume serially at 14,17 ,20 wks . The outcome was 
focussed on birth weight, anthropometric measurement at birth, & 
placental weight. The result of the study was the placental volume 
positively correlated with all birth measurements. The Head 
circumference was the strongest predictor of birth weight at 14 wks 
(p=0.014) & 17 wks (p= 0.012), but at 20 wks  abdominal 
circumference was the strongest predictor. Finally they have 
concluded that low birth weight was often preceded by small placental 
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volume in 2nd trimester. Hence placental volume may be a more 
reliable predictor of  birth weight than fetal anthropometry & it may 
be useful in early identification of  fetus at risk. 
 
HUMBERTO AZPURUA, EDMUND F.FUNAI, LUISA 
M.CORALLUZI53 
Conducted a prospective study involving 29 3rd trimester 
pregnancies & estimated placental volume with 2 dimensional 
ultrasonogram before 48 hrs of delivery. After delivery also they 
calculated placental volume, and compared these two. They found 
significant correlation between the estimated placental volume and 
actual placental volume after birth. They concluded that placental 
volume can be accurately predicted by 2 dimensional ultrasound with 
volumetric calculation. 
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MATERIALS AND METHODS 
This prospective analytical   study was conducted at The 
Institute of obstetrics and gynaecology, Egmore, Chennai  coming 
under the Madras medical college,  Chennai from 2011 to 2012.  
Ethical committee clearance was obtained to undergo the study.  
The  patients referred  as IUGR   beyond 34 wks up to  term  
were  carefully analysed. The inclusion criteria used were, 
1. with singleton pregnancy  
2. well  known gestational age   
3. without any maternal medical complications, 
4. with first trimester ultrasound for confirming the gestational 
age and second trimester ultrasound to rule out   fetal  anomaly and 
serial ultrasound to see the interval growth. 
These patients were screened with clinical method of measuring 
fundal height. If it was lagging behind 4 weeks for their gestational 
age, then they were subjected to ultrasound and  fetal biometry and 
estimated fetal weight were measured.  
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Estimated fetal weight of < 10th percentile for their gestational 
age with ultrasound were selected for the study after getting informed 
consent. 
Exclusion criteria: 
Patients with multiple pregnancy, abnormal placentation, fetal 
malformation were excluded. 
Patients with severe oligohydromnios in which there was 
difficulty in localising the placenta were excluded from this study. 
And also in patients in whom there was difficulty in localising 
as well as measuring the  placenta due to fundal or lateral wall 
insertion were excluded. 
Detailed history was taken & patients with hypertension, 
diabetes, other medical disorders were excluded to avoid errors in 
monitoring the perinatal outcome. 
Examination of the selected patients: 
Name, age, unit, Registration number, Address, socioeconomic 
status, occupation were noted. 
38 
 
In multigravidas, detailed history of previous pregnancies 
including duration of pregnancy, mode of delivery, birth weight of the 
baby, perinatal outcome and pregnancy complications like gestational 
hypertension, pre eclampsia, gestational diabetes mellitus were 
elicited. 
Details  of present pregnancy including last menstrual period, 
1st trimester ultrasonogram, any h/o bleeding episodes,  / h/o fever 
episodes in the first trimester were noted. 
Details about second trimester including the targeted ultrasound 
to rule out fetal anomaly, h/o iron and folicacid intake, immunisation, 
any history suggestive of preeclampsia were recorded. 
Regarding third trimester, the follow-up ultrasound to assess the 
interval growth, history suggestive of pre eclampsia were recorded. 
Detailed clinical examination of the patient was done & height, 
weight, BMI, blood pressure were noted . Routine laboratory 
investigations  also done. Obstetric  examination was done  & a lag in  
fundal height of  more than 4 weeks taken into consideration. Those 
patients selected for the study were subjected to ultrasound 
examination. 
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Ultrasound examination: 
The machine used for 2Dimensional ultrasound examination 
was GE with a 5 MHz curvilinear probe. 
Fetal parameters like BPD,HC ,AC, FL,  were measured as 
described below.Estimated fetal weight was calculated with the above 
measurements by ultrasound and confirmed whether it was <10th 
percentile. 
Amniotic fluid index was  also done. placental localisation was done .  
The probe was adjusted for seeing both edges of the placenta in 
the same image and the image was frozen. With this placental width 
and height  were measured. Then placental thickness was measured 
possibly at the level of cord insertion. 
Measurement of placental volume was done by using the 
convex-concave shell formula. 
V=piT/6×(4H(W-T) +W(W-4T)+4T2); 
H=PLACENTAL HEIGHT, 
T= PLACENTAL THICKNESS, 
W= PLACENTAL WIDTH.  
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Diagrammatic representation of measurement of placental volume 
 
 
This picture shows 2 dimensional measurement of placental width and 
thickness. 
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Doppler study was done on the umbilical artery, middle cerebral 
artery as described below. Umbilical cord was located in the pool of 
Amniotic fluid and the middle cerebral artery was localised in the 
transverse section of the fetal skull at the level of thalamus in the 
sylvian fissure. The doppler signals appropriate for the vessels were 
identified. The signals were recorded for a minimum of 5-8 cycles 
with blood flow velocity waveforms of equal shape and amplitude and 
of satisfactory quality were obtained. The image was frozen and the 
measurements of RI (RESISTANCE INDEX)  was taken. 
Cerebroplacental ratio was calculated from the RI of umbilical and 
middle cerebral artery (RI of MCA/ RI of UA).  Doppler was 
considered abnormal when the RI value above 95 th percentile for the 
gestational age in umbilical and middle cerebral artery or there was 
absent / reversal of diastolic flow in umbilical artery or  CPR <1. 
Patients with normal fetal growth were selected as control. The 
inclusion criteria for selection were same that of IUGR to avoid errors 
in comparison. Patients with singleton pregnancy, well known 
gestational age, appropriate interval growth in previous serial 
ultrasound, without any systemic medical disorder were included in 
the study. 
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Patients with multiple pregnancy, fetal anomaly, or abnormal 
placentation and with maternal complications were excluded. 
In this group also detailed history was elicited. Details of this 
pregnancy like last menstrual period, 1st trimester ultrasonogram, 2nd 
trimester anomaly scan,3rd trimester interval growth  were  noted. In 
multigravidas, history regarding previous pregnancy & its outcome 
and any pregnancy complications were recorded. 
Detailed clinical examination was done. ultrasonography was 
also done & the fetal biometry, AFI, placental localisation, placental 
volume were measured in the same way. Here also patients with 
difficulty in localising the placenta were excluded from this study. 
All cases were observed till delivery .patients were followed up 
with fetal surveillance with daily fetal movement count, modified 
biophysical profile , repeat ultrasonogram if needed to observe the 
interval growth. Once decided for termination, Placental volume by 2 
dimensional ultrasound  was repeated if done 48 hrs before delivery. 
Mode of delivery was noted. In case of vaginal delivery, careful 
intrapartum monitoring done. If decided for caesarean section, the 
indication was noted.  
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At delivery, baby  was looked for APGAR score at 1  and 5 
minutes. colour of liquor, meconium  staining of umbilical cord were  
noted. Birth weight of the baby was taken.  
After delivery of the placenta  the cord was immediately tied 
close to the insertion to prevent the loss of blood from the placenta. 
The remaining cord was cut. Membranes were trimmed from the edge.  
The placenta  was kept on a flat surface and maximum, minimal width 
were measured with an inch tape. Maximum height was measured. 
With all these measurements, placental volume was calculated by the 
following formula; 
V=pi ABH.               
 A=Major width,   
 B=Minor width,  
H=Height. 
The placental volume measured before delivery was compared 
with that of after delivery. 
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PLACENTAL MEASUREMENT AFTER DELIVERY 
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METHODS   OF   ULTRASOUND   AND DOPPLER                         
MEASUREMENT: 
BIPARIETAL DIAMETER: 
Biparietal diameter helps to determine the gestational age and 
type of IUGR. But using BPD alone for diagnosing IUGR has poor 
sensitivity.  According to Campbell S, Deuhurst (1971)54 when BPD is 
below 5 th percentile , 82% of birth weight are below 10 th percentile. 
BPD may also give false positive result due to alteration in shape of 
the head as in brachycephaly or dolichocephaly. 
It is a two dimensional  measurement. Any plane of section 
through 360 degree arc that passes through the thalami and 3rd 
ventricle is acceptable for measuring BPD & it is measured from outer 
edge of the fetal skull on the proximal surface to the inner edge of 
skull on the distal surface. 
HEAD CIRCUMFERENCE: 
HC is better than BPD in predicting IUGR as it is not subjected 
to variability. 
It is measured at the same level of BPD using the method of 
expanding ellipse. 
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FEMUR LENGTH: 
FL is an excellent parameter to calculate gestational age, as it is 
not significantly affected by IUGR.  
It is a single dimensional measurement. The transducer is 
aligned to the long axis of the diaphysis of the bone to obtain a proper 
plan of section .Only the ossified portions of  the diaphysis  and the 
metaphysis  are measured  .Proper alignment of the transducer to the 
long axis of the bone is ensured by demonstrating that both the 
femoral head or greater trochanter and the femoral condyle are 
simultaneously in the plane of section. 
ABDOMINAL CIRCUMFERENCE: 
AC has highest sensitivity and greatest negative predictive 
value in diagnosis of IUGR.AC value < 10 th percentile for gestational 
age has negative predictive value of  93% and positive predictive 
value of 47% in diagnosis of IUGR. AC value of < 5th percentile has 
negative predictive value of 93% and positive predictive value of 
67%. AC of > 25 th percentile has negative predictive value of > 95%. 
It is three dimensional  measurement.   The  AC is measured at 
a position where the transverse diameter of the liver is greatest. It is 
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determined sonographically  as the position where the right and left 
portal veins are continuous with one another. 
ESTIMATED FETAL WEIGHT: 
Determination of estimated fetal weight by ultrasonogram 
requires accurate measurement of BPD,HC , AC, FL. According to 
Ott, (1997)55,  fetal weight estimation has sensitivity of 
89%,specificity of 88%, positive predictive value of 45%, negative 
predictive value of 99% in detection of IUGR. 
According to Chervenac et al (1984)56 when EFW is below 
0.5% confidence limit the probability of IUGR  is 82% and if it is 
between 0.5%-20%  confidence limit, the probability is 24%. 
PARAMETER BPD AC FL EFW 
SENSITIVITY 75% 95% 45% 65% 
SPECIFICITY 70% 60% 97% 96% 
POSITIVE 
PREDICTIVE 
VALUE 
21% 21% 64% 65% 
NEGATIVE 
PREDICTIVE 
VALUE 
96% 99% 94% 96% 
 
48 
 
DOPPLER STUDIES: 
The Doppler principle was first described by Johann christian 
Doppler in 1842.The use of doppler in the evaluation of fetal 
circulation has been adequately assesed in  randomized control trials 
and it has been found to be useful. The use of doppler in obstetrics 
requires adequate understanding of feto-placental and materno-
placental circulation. The doppler study of arterial and venous system 
of the feto-placental unit has been found to be useful,  
-  In complementing other methods of fetal surveillance such as 
NST, BPP in more precisely determining the degree of fetal 
compromise. 
- as a follow up test when other tests of fetal well being give 
ambiguous results, 
- in identifying high risk of placental insufficiency and fetal 
complications, 
-   in evaluating the  presence and severity of fetal anemia. 
There are several methods of analysing doppler wave form  to 
provide  a quantitative index of vascular resistance namely S/D Ratio, 
PI(Pulsatility Index), RI(Resistance Index). The objective of these 
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indices is to obtain a numerical value from the wave form  , so that we 
can asses the resistance to the blood flow of the vessel being studied. 
S/D RATIO=Mean systolic velocity/Mean diastolic velocity. 
PI=systolic velocity-diastolic velocity/mean velocity. 
RI=systolic velocity-diastolic velocity/systolic velocity. 
In this study we have taken the RI as an index of vascular 
impedence. 
Umbilical artery: 
The umbilical artery doppler provides the index of resistance to 
blood flow on the fetal side of the placenta. 
A loop of umbilical cord midway between the fetal and 
placental insertion  was located. Because  measurement close to the 
placental insertion shows high resistance flow and close to the fetal 
insertion shows  low resistance.  That segment of umbilical cord is 
elongated so that 2 umbilical artery and 1 umbilical vein could be 
distinguished. Angle of insonation was adjusted to < 60 degrees. An 
optimum doppler signal was obtained and the Resistance  index was  
measured. 
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GESTATIONAL AGE RESISTANCE INDEX 
34 WKS 0.62-0.74 
35 WKS 0.61-0.73 
36 WKS 0.59-0.72 
37 WKS 0.58-0.71 
38 WKS 0.57-0.70 
39 WKS 0.56-0.69 
40  WKS 0.55-0.68 
 
The resistance to the  blood flow through the umbilical artery 
decreases as the gestational age advances .Whenever there is placental 
insufficiency,  there are certain adaptive changes that takes place in 
the fetal circulation which can be observed in doppler waveforms.  
The sequence of events are as follows. 
1. Increased umbilical artery resistance without centralisation of 
flow. 
2. Increased umbilical artery resistance with centralisation of flow. 
3. Absent diastolic flow in the umbilical artery. 
4. Reversed diastolic flow in the umbilical artery. 
5. Alteration in venous circulation. 
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The initial phases indicates the fetal compensatory mechanisms 
to increased placental vascular resistance. When the diastolic flow in 
the umbilical artery becomes absent or reversed, it indicates that the 
fetal compensatory mechanisms exhausted and hypoxia and acidosis 
has set in. Alterations in venous circulation indicates the fetus is in 
hemodynamic decompensation and at risk of imminent death. 
Middle  cerebral artery: 
When the placental resistance increased to a certain threshold, 
the fetus develops a compensatory response by increasing blood flow 
to the vital organs like Brain  & Heart , and decreases blood flow to 
peripheral organs.This is evidenced in doppler study as decrease in 
resistance of middle cerebral artery blood flow which  originally has 
high resistance flow. This centralization indicates the fetal 
compensatory mechanism to the increased  resistance to the blood 
flow. 
Section of fetal skull used for BPD measurement was obtained 
and then the transducer was angulated caudally till the middle cerebral 
artery courses along the sphenoid wings. The volume size and angle of 
insonation were adjusted after placing the cursor over the artery and 
appropriate signals were obtained and the RI was measured. 
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GESTATIONAL AGE RESISTANCE INDEX OF  
MCA 
34 WKS 0.73-0.86 
35 WKS 0.72-0.85 
36 WKS 0.70-0.83 
37 WKS 0.68-0.81 
38 WKS 0.66-0.80 
39 WKS 0.63-0.78 
40 WKS 0.61-0.76 
 
The MCA resistance index also decreases with gestational age 
but remains higher than that of umbilical artery. 
CEREBRO PLACENTAL RATIO: 
It is the ratio between RI of MCA & RI of UA. According to 
Arias (1994)57, CPR<1 identifies the fetuses at risk of IUGR and poor 
perinatal outcome.The  predictive value of the CPR loses after 34 
weeks (Bahado Singh et al 1999. 
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OBSERVATION AND RESULTS 
This prospective analytical study was conducted with 100 
IUGR patients as study group and 100 normal pregnancy as control 
group. The following observations were made.  
1. GESTATIONAL AGE: 
In our study IUGR above 34 weeks of gestation were taken 
excluding extreme prematurity. The number of patients in normal 
pregnancy were selected according to this gestational age for better 
comparison. The number of patients presented in both group were,  
GESTATIONAL AGE IUGR NORMAL 
PREGNANCY 
34-36 WKS 47 50 
36-37 WKS 22 25 
37-38 WKS 13 20 
38-40 WKS 8 5 
 
According to the above data, the commonest gestational age 
group presented  was 34-37 weeks (n=69). 
 
54 
 
2. MATERNAL AGE: 
In IUGR group ,71 patients were presented in the age group of 
28-36 years. So patients in the normal pregnancy group also selected 
according to this to avoid errors in comparison. The age wise 
distribution of patients in both age group was, 
AGE IUGR NORMAL 
PREGNANCY 
18-22 YRS 11 13 
23-27 YRS 15 20 
28-31 YRS 25 21 
32-36 YRS 41 44 
>36 YRS 8 1 
3. PARITY: 
In our study both primi gravidas and multigravidas presented 
equally & patients in normal group were also selected like that. 
PARITY IUGR NORMAL 
PREGNANCY 
PRIMI 49 48 
MULTI 51 52 
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4. PLACENTAL VOLUME: 
Placental volume was measured in all the patients in our study 
group by 2 dimensional ultrasound as described above with in 48 hrs 
of delivery. The average placental volume observed according to 
gestational age were as follows. 
GESTATIONAL AGE IUGR NORMAL 
PREGNANCY 
34-36 WKS 335 552 
36-37 WKS 424 578 
37-38 WKS 469 604 
38-40 WKS 574 647 
 
5. DOPPLER ANALYSIS: 
All patients in IUGR group were subjected to doppler study. 
The findings were, 
CPR <1 52 
CPR >1 48 
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6. MODE OF DELIVERY: 
All patients were observed till delivery. Mode of termination 
was noted. Method of induction, indications for caesarean section 
were observed. 
 
MODE OF DELIVERY NO OF PATIENTS 
VAGINAL 26 
LSCS 74 
 
 
7. BIRTH WEIGHT OF THE BABY: 
The birth weight of the baby in IUGR group was noted. 
BIRTH WEIGHT NO OF BABIES 
<1 KG 2 
1-1.5 KG 17 
1.6-2.0 KG 47 
2.1-2.5 KG 34 
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8. OUT COME OF THE BABY: 
The outcome of the babies in IUGR group was observed. 
Among 100 babies 61 babies had good outcome without any perinatal 
mortality or morbidity. The remaining 39 babies had adverse outcome 
in the form of IUD(2), neonatal death (9),low apgar (18),MSAF(10). 
Outcome of the babies No of babies 
Good outcome 61 
IUD 2 
NND 9 
Low APGAR 19 
MSAF 9 
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DISCUSSION 
The above datas obtained from this study were analysed by 
statistical methods appropriate for the variables compared. 
Comparison of variables between IUGR and NORMAL 
pregnancy  groups: 
1. GESTATIONAL AGE: 
In this study gestational age above 34 weeks were taken. This is 
because most of the patients referred from periphery to tertiary care 
centre as IUGR for NICU care in late third trimester only. Very 
Preterm IUGR were excluded from the study to avoid errors in 
assessing  perinatal outcome. 
Among 100 patients with IUGR, 76 patients were between 34-
37 weeks(76%).Patients between 38-40 weeks were 24 only 
(24%).This showed the incidence of early IUGR is more common than 
that of late IUGR. 
The number of patients with normal pregnancy were selected 
similar to the number of patients with IUGR in accordance to the 
gestational age. 
   This showed the maximum number of IUGR presented in this 
study was between 34
Among these patients
government and private hospit
IUGR and referred here for neonatal care.
The remaining 17 patients were diagnosed as IUGR at their first 
booking visit at IOG in 3 rd trimester.
 
 
 
0
10
20
30
40
50
60
34-36 wks
Gestational Age Distribution
59 
-36 weeks. 
, 83 patients were referred from various 
als as ?IUGR or diagnosed there as 
 
 
36-37 wks 37-38 wks 38-40 wks
 
IUGR
NORMAL
60 
 
Distribution of referral Patients
PHC
PVT HP
GH
REFERRAL NO OF PATIENTS 
FROM PRIMARY CARE 
HOSPITALS AS ? IUGR 
36 
FROM PRIVATE HOSPITAL 
WITH DOPPLER CHANGES 
19 
FROM PRIVATE HOSPITAL 
WITHOUT DOPPLER STUDY 
8 
FROM OTHER GOVT. 
HOSPITALS FOR  NICU CARE 
20 
 
 
       
 
 
 
 
 
 
This showed more number of patients were referred as 
suspected IUGR from various government hospitals including primary 
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health care centre as well as secondary care centre where facilities for 
proper evaluation of IUGR not available.                                                                                   
These patients were included in this study after confirming  
IUGR with clinical examination& previous  serial  ultrasonogram 
findings. 
2. MATERNAL AGE: 
In patients with IUGR, 71 patients were in the age group of  
28-36 years. 
This is comparable with the study by Odibo AO, Nelson D 
(2006)58  noted that there was a positive association with increasing 
maternal age& IUGR.  They concluded that advancing maternal age is 
an independent risk factor for IUGR.   
The patients in the control group with normal pregnancy also 
selected according to this to avoid errors in comparison. 
The most common age group presented was 32-36 yrs. 
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This showed there was positive correlation between advancing 
maternal age and IUGR. This denotes that advancing maternal age 
may be an independent risk factor for IUGR.                           
3.COMPARISON OF PARITY: 
In our study both primi and multi were presented equally. 
Taj mohammad, Asmat ara (2010)59 concluded that primiparity 
was also a significant risk factor for IUGR . Similar findings were 
reported by Fikree et al60 & Thompson et al61. 
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Patterson RM, Gibbs,Woods (1986)62 reported, the prevalence 
of recurrent IUGR was significantly related to the severity of growth 
restriction in previous pregnancy & severe placental insufficiency had 
10% recurrence risk. 
In our study group of IUGR, among the multigravidas 11 
patients had h/o previous low birth weight babies . Among the 11 
babies 3 were died in the neonatal period due to sepsis. 
The rest of the multigravidas had no details regarding previous 
pregnancy. 
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PARITY H/O IUGR GOOD 
OUTCOME 
NND 
1 LIVE CHILD 9 8 1 
>1 LIVE 
CHILD 
- - - 
NO LIVE 
CHILD 
2 - 2 
                             
The recurrence rate could not be analysed properly because of 
insufficient datas. 
4. COMPARISON OF PLACENTAL VOLUME: 
De paula CF,ruano R,Campos JA (2008)63 developed 
nomograms for placental volume  in normal pregnancies from 12-40 
weeks by measuring it with 3 dimensional ultrasonography. The 
placental volume measured in our study was compared with that. 
Gestational Age PV 10 th 
percentile (cm3) 
PV 50 th 
percentile (cm3) 
PV 90 th 
percentile (cm3) 
34 wks 189 353 530 
35 wks 195 366 549 
36wks 201 378 568 
37 wks 207 390 587 
38 wks 213 403 606 
39 wks 219 415 624 
40 wks 225 427 643 
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Based upon the above nomograms, the  Placental volume was 
graded into 3 types as follows, 
1. Grade -1: The placental volume  falls above 50th percentile but 
below 90th percentile. 
2. Grade-2: The placental volume falls below 50 th percentile but 
above10 th percentile. 
3. Grade-3: There is severe reduction in placental volume & falls 
below 10 th percentile. 
The average placental volume observed according to gestational 
age in pts with IUGR. 
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     When comparing the placental volume of 34-37 weeks with that 
of 38-40 weeks there is more significant reduction of placental volume 
was noted in the early group of IUGR which were of preterm 
pregnancies. As the gestational age advances the reduction in the 
placental volume became less. This indicates the placental 
insufficiency may be more severe when it occurs in preterm than in 
term pregnancy.                                                                                                                          
 The placental volume according to the gestational age further 
divided into 3 grades and compared.                                                                                                                    
GESTATIONAL 
AGE 
GRADE 1 GRADE 2 GRADE 3 TOTAL 
34-36 WKS 15 26 6 47 
36-37 WKS 12 8 2 22 
37-38 WKS 20 1 2 23 
38-40 WKS 7 - 1 8 
 
This shows the more earlier the gestational age, severe 
reduction in the placental volume. Near term there is only mild 
reduction in the placental volume. 
   
   
 
 Comparing the grading of the placental volume, m
patients had grade1
volume was above 50 th percentile
volume noted only in 11
has grade 2, grade 3 placental volume than grade 1 placental volume. 
Whereas in 38-40 weeks of gestation, most of the patients had grade 1 
placental volume. 
insufficiency is more when compared to late onset IUGR
The average placental volume observed in normal pregnancy.
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When comparing 
IUGR pregnancy , the following was observed.
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 90 th percentile. 
the average placental volume of  normal & 
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This figure 
volume in IUGR group when compared with normal pregnancy
gestational age group
significant in the early gestational group. As the gestational age 
advances the difference in placental volume between IUGR and 
normal pregnancy becomes less significant.
On statistical analysis the following was observed.
STUDY 
GROUP PLACENTAL 
IUGR 
NORMAL 
PREGNANCY 
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Normal IUGR
shows there is significant reduction in placental 
. The reduction in placental volume is more 
 
 
MEAN 
VOLUME 
STANDARD 
DEVIATION 
SIGNIFICANCE
402.66 38.679 
584.4 127.924 
 in all 
 
0.001 
0.001 
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p=0.001** Highly significant.(Levene s T-Test) 
When comparing the average placental volume of all gestational 
age group in IUGR with that of normal group, there is statistically 
significant reduction is noted. 
With the above findings, we can conclude that in IUGR  
pregnancies without any identifiable aetiology, the placental 
insufficiency of unknown cause  plays a major role.   
2. COMPARISON OF PLACENTAL GRADING WITH 
MATERNAL AGE: 
On comparing the placental grading with maternal age the 
following was observed. 
MATERNAL 
AGE 
GRADE 1 GRADE-2 GRADE 3 TOTAL 
18-22 YRS - 1 10 11 
23-27 YRS 7 8 1 15 
28-31 YRS 13 12 - 25 
32-36 YRS 30 10 1 41 
>36 YRS 4 4 - 8 
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This diagram shows the comparison of placental grading with 
maternal age. Here, more severe placental volume reduction was 
noticed in younger age group. With advancing maternal age only mild 
reduction in placental volume was observed. In the commonest age 
group presented in this study of 32-36 years, 55.55% of  these patients 
had only grade1 placental volume.In the contrary, 10 patients among 
11 in the age group of 18-22 had grade 3 placental volume. 
This is comparable with a study conducted by Taj 
Muhammad,Asmat Ara (2010)64 who reported younger maternal age 
is a risk factor for IUGR by comparing with a study by Jamal et al,& 
Ferraz et al65. 
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3. COMPARISON OF PLACENTAL GRADING WITH 
PARITY: 
When comparing the parity with placental volume grading the 
following findings were noted. 
PARITY GRADE 1 GRADE 2 GRADE 3 TOTAL 
PRIMI 20 19 10 49 
MULTI 34 16 1 51 
In our study  even though both primi & multi were presented equally. 
 
This diagram represents the comparison of placental grading 
with parity. Here primigravidas had severe reduction in placental 
volume when compared to mutigravidas.   This is comparable with the 
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study by Taj mohammad, Amsat Ara (2010) who reported that, 
primiparity was also a significant risk factor for IUGR at multivariable 
level. Similar findings was also reported  by Fikree et al & Thompson 
et al.   
4. DOPPLER ANALYSIS: 
All the patients in IUGR group were subjected to arterial 
doppler & the Cerebroplacental ratio was calculated. Venous doppler 
was not done. The reports were analysed based upon the 
Cerebroplacental ratio. 
CPR GOOD OUTCOME ADVERSE 
OUTCOME 
<1 20 32 
>1 31 17 
 
In patients with CPR<1 the adverse outcome was more when 
compared with CPR>1. 
On analysing the datas with placental volume grading, the 
following was observed. 
 
 PLACENTAL 
VOLUME 
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volume is associated with
 
 
 
35
0
5
10
15
20
25
30
35
40
74 
CPR <1 CPR>1
22 
19 
11 
 placental volume is associated with less
All patients with Severe reduction in placental 
 doppler changes.  
16
19
22
Grade 1 Grade 2
Doppler and Placental Grading
CPR >1 CPR <1
 
32 
16 
- 
 
 
0
11
Grade 3
75 
 
This is comparable with the study done by Dudarenicz 
L,Kaluzewski B (2006)66 in which they compared  placental volume 
with doppler study in 82 pregnancies between 14-40 wks of gestation. 
They concluded that PI of umbilical artery correlated negatively with  
 
Placental volume, PI of MCA showed no significant correlation 
whereas the Cerebroplacental ratio showed significant positive 
correlation with placental volume. 
On statistical analysis of doppler changes with perinatal 
outcome the following was noted. 
p=0.009** Highly significant. (pearsons chi-square test) 
 Good Outcome Adverse Outcome 
CPR< 1 20 32 
% within CPR 39.2% 60.8% 
% within Outcome 38.5% 64.6% 
CPR> 1 31 17 
% within CPR 65.3% 34.7% 
% within Outcome 61.5% 35.4% 
 This shows th
by CPR is 60.8% and the specificity is 65
 5. The mode of delivery in 
All the patients in the study group were observed till delive
Patients were followed up by antenatal fetal surveillance with daily 
fetal movement count, Non stress test, Modified Biophysical profile, 
weekly doppler, serial ultrasound to monitor  the  interval growth. 
After deciding for termination of pregnancy, p
measured if it was done 48 hrs before, Bishop scoring, Non stress test, 
Amniotic fluid index all were repeated. The mode of termination was 
decided based upon all these parameters. Those who were planned for 
31
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ry. 
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vaginal delivery were induced with cerviprime gel & were carefully 
monitored for signs of fetal distress. 
MODE OF 
DELIVERY 
GRADE 1 GRADE 2 GRADE 3 TOTAL 
SPONTANEOUS 
VAGINAL 
DELIVERY 
1 1 - 2 
INDUCED 
VAGINAL 
DELIVERY 
12 6 6 24 
CAESAREAN 
SECTION 
41 28 5 74 
TOTAL 54 35 11  
   
                                                                                                                                                            
Mode of Delivery
VAGINAL LSCS
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Vaginal delivery was very low in all IUGR group irrespective 
of placental volume. Total no of caesarean section was high when 
compared to vaginal delivery. 
The indications of caesarean section were the following. 
INDICATIONS NO OF 
DELIVERY 
PERCENTAGE 
FAILED INDUCTION 32 43.24% 
NON REASSURING 
CTG 
23 31.08% 
SEVERE 
OLIGOHYDROMNIOS 
8 10.81% 
BREECH 11 14.86% 
Among these indications, failed induction was more in primi 
gravida  with gestational age between 34-37 wks. This was mainly due 
to poor Bishop score at the time of induction. Some patients in the 
group of induction were taken up for LSCS for the signs of 
intrapartum fetal distress. In the Electronic fetal heart rate monitoring  
,the incidence of non reassuring heart rate pattern was observed more 
with placental volume <10 th  percentile.  The commonest non 
reassuring pattern observed was loss of beat to beat variability 
followed by absence of accelerations. Spontaneous  decelerations were 
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observed in patients with very low placental volume. Severe 
oligohydromnios was also more in placental volume <50 th percentile. 
Some patients were taken up for caesarean section without induction 
such as breech, oligohydromnios, non reassuring heart rate pattern in 
NST. Other patients underwent caesarean section were due to failed 
induction, signs of intrapartum fetal distress. The outcome of babies of 
these 2 groups was as follows: 
Elective LSCS 29 
Emergency LSCS 43 
 
The indications for elective LSCS were Breech, 
oligohydromnios, non reactive CTG. The indications for emergency 
LSCS were non progression of labour, failed induction, intrapartum 
fetal distress. The outcome of  these 2 groups are as follows. 
Outcome Elective LSCS Emergency LSCS 
MSAF 1 (3.44%) 9 (20.93%) 
Low APGAR 6 (20.68%) 13 (30.23%) 
Good 22 (75.86%) 21 (48.83%) 
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The incidence of MSAF and low APGAR were more with 
emergency LSCS group. The fetal outcome was better in elective 
LSCS when compared with emergency LSCS. 
Distribution of birth weight in the IUGR group. 
The birth weight of the babies were compared with placental volume 
and analysed. 
BIRTH 
WEIG
HT 
PLACENT
AL 
VOLUME 
GRADE 1 
PLACENT
AL 
VOLUME  
GRADE 2 
PLACENT
AL 
VOLUME  
GRADE 3 
TOT
AL  
PERCENT
AGE 
< 1KG - - 2 2 2% 
1-1.5 
KG 
6 2 9 17 17% 
1.6-2.0 
KG 
20 27 - 47 47% 
2.1-
2.5KG 
28 6 - 34 34% 
                        
 In grade 3 placental volume the birth weight of the babies was 
significantly lower than that of grade 1 and grade 2 placental volume.   
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This diagram shows the birth weight distribution according to 
placental grading. Very low birth weight babies were observed in the 
group of  severe reduction in placental volume. In patients with grade 
1& grade 2  placental volume, the birth weight was 1.6-2.5 kgs. This 
shows a positive correlation between placental volume and birth 
weight. 
Placental 
volume 
Average birth 
weight 
S.D. Significance 
Grade 1 1.99kg 0.30 0.001 
Grade 2 1.82kg 0.21 0.001 
Grade 3 1.25kg 0.6 0.001 
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p=0.001** highly significant. 
When comparing the average birth weight of grade 1& grade 2 
placental volume, there was no significant difference between these 
two. When comparing that of grade1& grade 2 with grade 3 there was 
significant reduction in birth weight noted. 
This is comparable with a study done by Thame M,Osmond, 
Wilks (2001)67 in which they concluded that low birth weight was 
often preceded by small placental volume in second trimester. 
placental volume may be a more reliable predictor of size at birth than 
fetal anthropometric measurements and may be useful in early 
identification of fetus with perinatal risk. 
The perinatal outcome of the babies are as follows. 
The perinatal outcome of the babies in IUGR group are 
analysed and the results  are as follows. 
PERINAT
AL 
OUTCOM
E 
PLACENT
AL 
VOLUME 
GRADE 1 
PLACENT
AL 
VOLUME  
GRADE 2 
PLACENT
AL 
VOLUME 
GRADE 3 
PERCENTA
GE 
ADVERSE 10 18 11 39 % 
GOOD 44 17 - 61% 
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In patients with grade 1 placental volume , the overall outcome 
of the baby was good. 
In patients with grade 2 placental volume, both good and 
adverse outcome were almost equal. 
In grade 3 severe placental volume reduction all babies had 
adverse outcome only. 
On analysing the adverse outcome the following was noted. 
PERINATAL 
OUTCOME 
PLACENTAL 
VOLUME 
GRADE 1 
PLACENTAL 
VOLUME 
GRADE 2 
PLACENTAL 
VOLUME 
GRADE 3 
TOTAL 
IUD - - 2 2 
     
LOW APGAR AT 
BIRTH 
6 10 3 19 
FETAL 
DISTRESS/MSAF 
3 5 1 9 
EARLY 
NEONATAL 
DEATH 
1 3 5 9 
NO ADVERSE 
OUTCOME 
44 17 - 39 
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In patients with grade 1  placental volume  the outcome of fetus 
was good . In this group 6 babies showed low Apgar at birth(11.11%)   
& 3 babies showed signs of fetal distress like MSAF  (5.55%). Among 
these babies with perinatal morbidity,2 babies with meconium 
aspiration and 1 baby with low apgar at birth  died in the early 
neonatal period after admission in the neonatal care unit (33.33% 
mortality).The other babies  recovered well. Another 1baby was died 
in the early neonatal period due to very low birth weight and sepsis 
(1.85%) .44 babies had good perinatal outcome without  any 
morbidity and mortality(81.48%). The overall good outcome of all 
babies in this group including those recovered after perinatal 
morbidity was  92.59%. 
In patients with  grade 2 placental volume, the incidence of fetal 
distress and low Apgar were more.  Low Apgar was noticed in 10 
babies(28.57%).The incidence of fetal distress  with meconium 
aspiration was noticed in 5 babies (14.28%).Among these babies with 
above perinatal morbidity,3 babies with severe meconium aspiration 
syndrome and 2 babies with poor apgar, totally 5 babies died even 
with good neonatal critical care(33.33%).Other babies recovered well. 
17 babies had no adverse outcome(48.57%).  Moreover 3 babies were 
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died in the early neonatal period due to sepsis (8.57%) in this 
group.The overall good outcome of babies in grade 2 placental volume 
when considering those babies recovered from initial perinatal 
morbidity was 62.85% which is lower than that of grade 1 placental 
volume. 
In patients with grade 3  placental volume  all babies had 
adverse outcome only. There was 2 IUD (18.18%) mainly due to 
severe IUGR and very low birth wt (950 gms& 850 gms). 3 babies 
were born with low Apgar(27.27%),  and 1 baby born with severe 
fetal distress due to meconium aspiration (9.09%) . All these 4 babies 
died in the early neonatal  period even with good neonatal intensive 
care.5 babies died in the intensive care unit after admission due to 
delayed complications like sepsis (45.45%). The adverse outcome of 
babies in grade 3 placenta was 100%. 
On statistical analysis the following was observed. 
Placental 
volume 
Good out come Adverse 
outcome 
Significance 
Grade 1 81.48% 18.52% 
0.003 Grade 2 48.57% 51.43% 
Grade 3 - 100% 
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p=0.003** Highly significant (pearson chi-square test). 
The percentage 0f good outcome in grade 1 placental volume 
was 81.48% and for adverse outcome it was 18.52%  
The percentage of good outcome in grade 2 placental volume 
was 48.57% for adverse outcome it was 51.43% .This showed when 
the placental volume goes down there was  an increase in adverse 
outcome. 
The percentage of adverse outcome in grade 3 placental volume 
was 100%.So it predicts poor perinatal outcome. 
This shows the positive correlation between placental volume and 
perinatal outcome. 
 COMPARISON OF PLACENTAL VOLUME BEFORE AND 
AFTER DELIVERY: 
Following the delivery of the placenta, the umbilical cord was 
tied close to its insertion preventing blood loss from the placenta. The 
edges were trimmed of the membranes, measurements were taken to 
calculate the placental volume. on comparing these two the following 
findings were observed. 
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The average placental volume measured by ultrasonogram & 
after delivery in IUGR group was, 
GESTATIONAL 
AGE 
PV BY USG( cm3) PV AFTER 
DELIVERY cm3 
34-36 WKS 335 329 
36-37 WKS 424 417 
37-38 WKS 469 455 
38-40 WKS 574 580 
 
There was no significant difference noted between the placental 
volume measured before delivery by two dimensional ultrasound and 
that measured after delivery. This denotes that the measurement of 
placental volume by two dimensional ultrasound in the antenatal 
period is an effective method. 
The average placental volume in normal group before & after 
delivery was, 
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GESTATIONAL 
AGE 
PLACENTAL 
VOLUME BY USG 
PLACENTAL 
VOLUME AFTER 
DELIVERY 
34-36 WKS 552 565 
36-37 WKS 578 590 
37-38 WKS 604 613 
38-40 WKS 647 635 
 
In these group also both measurements were correlated well.  
This was comparable with the study by Humberto Azprurua, 
Edmund F68 who noticed significant correlation between placental 
volume measured by 2 dimensional ultrasound & placental volume 
measured after delivery and they found the mean error between these 
methods was only 16%.                                                                                                     
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SUMMARY 
This was a prospective analytical study. 
100 patients with singleton pregnancy after confirming IUGR 
were included in this study. 100 patients with singleton uncomplicated 
pregnancy were selected as control in such a way to match with the 
variables in IUGR group. 
76% 0f patients in IUGR group was in 34-37 weeks of 
gestational age. The common maternal age group presented was 32-36 
years. Both primigravida and multigravida were presented equally. 
For all patients general and obstetric examinations were done. 
All patients were subjected to ultrasound examination. Fetal 
biometry including BPD,HC ,AC ,FL, EFW and AFI  were measured. 
Placental localisation was done. placental volume was measured. 
Doppler study of umbilical and middle cerebral artery was done 
for all patients in the group of IUGR. Cerebroplacental ratio was 
calculated from the resistance index of middle cerebral and umbilical 
artery for all patients underwent doppler study. 
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All patients were followed up till delivery. The placental 
volume measurement was repeated if it was done 48 hrs before 
delivery. The mode of delivery and the indication for LSCS were 
noted. 
Birthweight of the baby was noted. APGAR at 1 & 5 minutes 
were observed. All perinatal morbidities like meconium aspiration, 
low APGAR were noted. All babies were followed up till discharge. 
After delivery again the placental volume was measured. 
The placental volume measured by ultrasound was compared 
with that measured after delivery. 
The results were compared with that of normal pregnancy. 
The average placental volume in normal pregnancy was  
595.25 cm3 
The average placental volume in IUGR pregnancy was 450 cm3 
This shows a significant difference in placental volume between 
these group. On statistical analysis, this showed significant 
difference.p=0.001** (highly significant; Levenes T-Test). 
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The placental volume done by ultrasound before delivery was 
compared that of measured after delivery. 
The average placental volume measured after delivery in 
normal pregnancy was  600.75 cm3. The average placental volume 
after delivery in IUGR group was 445.25 cm3. These value did not 
show much difference that of ultrasound measurement before delivery. 
The incidence of  LSCS  was high in the group of IUGR(74%). 
In case of emergency LSCS the perinatal morbidity in the form of 
MSAF was more when compared with the elective LSCS 
group(20.3% Vs 3.4%).The overall good outcome in elective LSCS 
group was 75.86% and in emergency  LSCS group it was 62.79%. 
This significant difference indicates intra partum fetal asphyxia that 
occurred with induction of labour which is a well expected 
complication in IUGR.  
The average  birthweight of the babies in grade 1 placental 
volume was 1.99 kgs and in grade 2 placental volume it was 1.82 kgs. 
These 2 did not show much difference. The average birth weight in 
grade 3 placental volume was 1.25 kgs. This showed significant 
difference in average birth weight. 
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When the placental volume was compared with the perinatal 
outcome of the baby, in grade 1 placental volume, there was 81.48% 
good outcome and 18.52% adverse out come & in grade 2 placental 
volume, the good outcome had come down to 48.57% and the adverse 
outcome increased to 51.43% whereas in grade 3 placental volume 
there was 100% adverse outcome only. This showed that the placental 
volume had good correlation with the fetal outcome. 
This study showed positive correlation between the severity of 
IUGR and placental volume. It also predicted the adverse perinatal 
outcome of the fetus clearly. Hence this can be taken as one of the 
methods of predicting adverse neonatal outcome in IUGR. 
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CONCLUSION 
Healthy baby and healthy mother are the goal of obstetrical 
management. 
The diagnosis of  Uteroplacental insufficiency , the major cause of 
IUGR,identifies the group of fetuses who are at incresed risk for 
perinatal complications. 
Ultrasonography plays a major role in early diagnosis of IUGR. 
Doppler ultrasonogram helps in  identifying  fetuses already in 
hypoxia and acidemia so that early interventions  could be done to 
reduce perinatal complications. But it needs costly equipment and 
trained personale which limits its usefulness in developing country 
like India. 
Placental volume has positive correlation with birthweight of the baby 
and perinatal complications. 
Estimation of placental volume by simple 2 dimensional ultrasound 
could be a better alternative method of antenatal fetal surveillance in 
IUGR  where doppler ultrasound is not available.  
  
PROFORMA 
Name :     Age:   Ip no: 
Address:      Date of admission: 
Socio economic status:    Education: 
Obstetric code:     LMP: EDD: 
Menstrual history: Regular/Irregular: 
Sure of LMP:       Yes/No 
Marital history:   Md since: 
Consanguinity: 
Obstetric history: 
Past history: 
H/o HT/DM/TB/BA/ HEART DISEASE/EPILEPSY/CHRONIC 
RENAL DISEASE/CONNECTIVE TISSUE DISORDER. 
Family history: 
Personal history: 
 
  
GENERAL EXAMINATION: 
HT:     WT:   BMI: 
Built:   Thin     /       Average    /        obese 
Pallor  /  Jaundice  / clubbing  /  cyanosis  /Pedal edema  /  
Lymphadenopathy 
VITALS:  Temp: Pulse rate:   BP:    RR: 
Breast:                                    Spine:                           Thyroid: 
CVS:                                           RS: 
Examination of the Abdomen : 
                                  Fundal ht: 
                                             FH: 
                    Liquor adequacy: 
INVESTIGATIONS: 
                       URINE-    Alb:  Sugar:    Dep:                                               
                      BLOOD- Hb:    PCV:          Platelets:                                           
 
  
 BLOOD: Urea:   Sugar:   Creatinine:                                                       
Blood G&T:        HIV:                   VDRL:              HBSAG: 
ULTRASONOGRAM: 
                                                                         
            1TRIMESTER    2TRIMESTER       3TRIMESTER       
BPD 
 
   
AC 
 
   
FL 
 
   
EFW 
 
   
GA 
 
   
PLACENTA 
 
   
AFI 
 
   
  
DOPPLER STUDY: 
UMBILICAL ARTERY RI: 
MIDDLECEREBRAL ARTERY RI: 
CPR: 
PLACENTAL VOLUME: 
DELIVERY:   
VAGINAL:         SPONTANEOUS:                INDUCED:  
LSCS :                  ELECTIVE / EMERGENCY   
OUTCOME: 
IUD /Still born: 
Birth wt:                      Apgar:                           
Liquor:      clear /meconium 
Placental volume: 
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CONSENT FORM 
STUDY TITLE :  COMPARATIVE STUDY OF PLACENTAL 
VOLUME IN NORMAL PREGNANCY AND 
INTRA UTERINE GROWTH RESTRICTION  
STUDY CENTRE:   Institute of Obstetrics and 
Gynaecology,Egmore,Chennai  
Participant Name :   Age:            Sex:          I.D.No.: 
I confirm that I have understood the purpose of the above study. 
I have the opportunity to ask the questions and all my questions and 
doubts have been answered to my satisfaction.  
I understand that my participation in the study is voluntary and 
that Iam free to withdraw at any time without giving any reason.  
I understand that the investigator, regularity authorities and the 
ethics committee will not need my permission to look at my health 
records both in respect to the current study and any further research 
that may be conducted in relation to it, even if I withdraw from the 
study. I understsnd that my Identity will not be revealed in any 
information released to third parties of published, unless as required 
under the law. I agree not to restrict the use of any results that arise 
from the study. 
  
I hereby consent to participate in this study titled 
"COMPARATIVE STUDY OF PLACENTAL VOLUME IN 
NORMAL PREGNANCY AND INTRA UTERINE GROWTH 
RESTRICTION" 
Signature of Investigator:                                                       Place:  
 
Study Investigators Name:                                                    Date : 
 
Signature/thumb impression of patient 
                                                 Thanking you,  
                                                                                     Yours faithfully, 
 
  
MASTER CHART 
     
S.No. Name Age Obst Code G/A 
(LMP) 
G/A 
(USG) 
MCA 
(RI) 
UA 
(RI) 
CPR PV(USG) PV(del) Delivery IND BW Outcome  
1 Sai subha 20 Primi 34-35 26-27 0.6 0.7 <1 185   (III) 175 Lscs Oligo 1.2 NND 
2 Meera 22 G2A1 34-35 28-29 0.65 0.74 <1 195   (III) 190 LSCS Fail ind 1.3 Low apg 
3 Ansari 21 G2P1L1 35-36 28-29 0.64 0.76 <1 176   (III) 170 Vaginal  900gms IUD 
4 Ramani 20 Primi 33-34 29-30 0.7 0.8 <1 190   (III) 196 Lscs Oligo 1.4 Low apg 
5 Lakshmi 19 Primi 34-35 24-25 0.7 0.96 <1 160   (III) 150 Vaginal  850gms IUD 
6 Subha 19 Primi 34-35 26-27 0.6 0.75 <1 185   (III) 195 Lscs Fail ind 1.4 Low apg 
7. Nabeesa 23 Primi 36-37 32-31 0.8 0.7 >1 325   (II) 315 Vaginal  1.7 Good  
8. Vimala 24 G2A1 34-35 32-31 0.76 0.64 >1 345     (II) 330 Vaginal  1.8 Good 
9. Punitha  24 G2P1L1 34-35 29-30 0.7 0.8 <1 330     (II) 325 LSCS Oligo 1.9 Good 
10. Anitha  27 G3P1L1A1 34-35 32-31 0.7 0.68 >1 315     (II) 303 LSCS Breech 1.6 Good 
11. Rajeswari 25 Primi 35-36 32-31 0.8 0.9 <1 324   (II) 335 LSCS Oligo 1.8 Low Apg 
12. Vanitha  26 G2P1L0 34-35 29-30 0.7 0.82 <1 340    (II) 332 LSCS Fail Ind 1.7 Low Apg 
13. Valli 25 G2A1 35-36 31-32 0.7 0.82 <1 345    (II) 360 LSCS Fail Ind 1.8 Good 
14. Ranjani 25 G3P1L1A1 36-37 32-33 0.9 0.8 >1 350    (II) 355 LSCS Breech 1.9 Good 
15. Dhanam 27 G3P1L1A1 35-36 31-32 0.86 0.74 >1 368    (I) 375 Vaginal   2.0 Good  
16. Divya  28 Primi 33-34 32-31 0.8 0.74 >1 346    (II) 340 LSCS Faild 
Ind 
1.8 Low Apg 
17. Kalaivani 29 G3P2L2 34-35 32-33 0.8 0.72 >1 416    (I) 400 LSCS Fail Ind 1.9 Low Apg.  
18. Lakshmi 29 G4P1L1A2 35-36 32-31 0.9 0.82 >1 328    (II) 325 LSCS Oligo 1.9 Good 
19. Kavitha  30 Primi 35-36 32-33 0.7 0.8 <1 315    (II) 324 LSCS Breech 1.7 Low Apg. 
20. Sharmila  31 G2P1L1 35-36 31-32 0.7 0.68 >1 325     (II) 315 LSCS Faild 
Ind 
2.0 Good 
21. Vasuki 31 G3P2L1 34-35 32-31 0.8 0.9 <1 300     (II) 315 LSCS Oligo 1.9 Low Apg.  
22. Girija  28 Primi 34-35 32-31 0.7 0.68 >1 275     (II) 280 LSCS Faild 
Ind 
1.8 Low Apg.  
23. Prema  29 Primi 35-36 32-33 0.8 0.7 >1 486     (I) 495 LSCS Breech 2.2 Good  
24. Shoba  31 G5P1L1A2 35-36 31-32 0.8 0.7 >1 315     (II) 305 LSCS Faild 
Ind 
1.9 Good  
 
 
  
25. Selvi 30 Primi 35-36 32-31 0.8 0.74 >1 430      (I) 415 LSCS Faild 
Ind 
2.1 Good  
26. Parvathi 29 G2P1L1 35-36 31-32 0.8 0.84 <1 268    (II) 250 LSCS Faild 
Ind 
2 Good 
27 Sangeetha  28 Primi 34-35 32-31 0.8 0.76 >1 475      (I) 482 LSCS Oligo 1.9 Low Apg. 
28. Pushpa 29 Primi 34-35 29-30 0.7 0.84 <1 328     (II) 345 LSCS Faild 
Ind 
1.9 Good 
29. Kiruba 32 Primi 33-34 29-30 0.7 0.68 <1 386      (I) 370 Vaginal   1.4 NND  
30. Sumathi 34 G3P2L0 35-36 31-32 0.82 0.74 >1 480      (I) 500 LSCS Breech 2.1 Good 
31. Shanthi 34 G2P1L0 34-35 32-31 0.84 0.76 >1 496     (I) 525 LSCS Faild 
Ind 
2.0 Good 
32. Sajeetha 33 G4P1L1A2 36-37 32-33 0.8 0.76 >1 502      (I) 535 LSCS Faild 
Ind 
2.3 Good 
33. Sagunthala 36 Primi 33-34 32-31 0.76 0.84 <1 325    (II) 330 Vaginal  1.7 Low Apg. 
34. Asha 35 G2A1 33-34 31-32 0.8 0.74 >1 326     (II) 330 LSCS Faild 
Ind 
1.8 Low Apg. 
35. Ramya  35 Primi 34-35 31-32 0.7 0.96 <1 388      (I) 400 LSCS Faild 
Ind 
1.5 NND 
36. Nithya 32 G3P1L1A1 33-34 32-31 0.8 0.76 >1 315     (II) 320 LSCS Faild 
Ind 
1.6 Low Apg. 
37. Jaya 33 G2A1 35-36 32-33 0.8 0.72 >1 515      (I) 545 Vaginal  2.2 Good  
38. Amutha  33 G2P1L1 34-35 31-32 0.9 1.1 <1 270     (II) 295 Vaginal   2.2 Good 
39. Malathi 35 G3P2L2 34-35 32-31 0.8 0.76 >1 383      (I) 400 LSCS Oligo 2.0 Good 
40. Deepa 34 G3P1L1A1 34-35 32-31 0.9 0.86 >1 254     (II) 275 LSCS Faild 
Ind. 
1.7 Low Apg. 
41. Latha  32 Primi 35-36 32-33 0.74 0.86 <1 325     (II) 330 Vaginal  2.2 Good 
42. Selvi 33 G2A1 34-35 31-32 0.7 0.84 <1 315     (II) 310 Vaginal   2.1 Good 
43. Bala 36 G2P1L1 34-35 32-31 0.7 0.72 <1 325     (II) 335 LSCS CTG 
NR 
1.8 Good 
44. Malini 35 G3P1L1A1 34-35 32-31 0.8 0.76 >1 366      (I) 350 LSCS Faild 
Ind 
1.9 Good 
45. Sathya 33 G3A2 34-35 31-32 0.84 0.76 <1 386      (I) 395 LSCS Faild 
Ind 
2.0 Good 
46. Valli 34 G2P1L1 34-35 30-31 0.76 0.86 <1 278     (II) 250 LSCS Faild 
Ind 
1.6 NND  
47. Bhavani 37 Primi 35-36 31-32 0.7 0.86 <1 416      (I) 440 LSCS Breech 1.9 Good 
48. Stella  32 G2P1L1 36-37 33-34 0.76 0.68 >1 505      (I) 525 LSCS Breech 2.1 Good 
  
49. Jaya 37 G3P2L0 34-35 29-30 0.68 0.84 <1 290     (II) 275 LSCS CTG 
NR 
1.6 Low Apg. 
50. Lalitha 32 G2P1L1 34-35 32-33 0.82 0.76 >1 330    (II) 345 LSCS CTG 
NR 
1.8 Low Apg. 
51. Praba 35 G2P1L1 35-36 32-33 0.86 0.73 >1 414     (I) 420 Vaginal  2.1 Good 
52. Saraswathi 36 Primi 36-37 33-34 0.8 0.74 >1 496     (I) 515 Vaginal  2.0 Good 
53. Neela  21 Primi 36-37 33-34 0.74 0.86 <1 188   (III) 200 Vaginal  1.2 NND 
54. Devi 21 Primi 36-37 30-31 0.8 0.96 <1 190   (III) 210 LSCS CTG 
NR 
1.3 MSAF. 
55. Suganya  20 Primi 36-37 33-34 0.8 0.76 >1 366     (II) 375 LSCS Faild 
Ind 
2.1 Good 
56. Rekha 24 G2A1 36-37 32-33 0.72 0.86 <1 588      (I) 595 LSCS CTG 
NR 
2.2 Good 
57. Lally 27 G2PlL1 36-37 33-34 0.86 0.7 >1 590      (I) 605 Vaginal  2.4 Good  
58. Sivakami 27 G3P1L1A1 36-37 34-35 0.96 0.72 >1 582      (I) 575 Vaginal  2.3 Good 
59. Radhi 28 G3A2 37-38 33-34 0.92 0.76 >1 586      (I) 575 LSCS Breech 2.3 Good 
60. Zeenath 30 Primi 36-37 32-33 0.76 0.92 <1 550      (I) 565 LSCS CTG 
NR 
2.1 Good 
61. Selvi 30 G2P1L1 36-37 33-34 0.8 0.76 >1 344     (II) 360 LSCS Faild 
Ind 
2.0 Good 
62. Thilaka 31 G4P1L1A2 37-38 33-34 0.78 0.96 <1 572      (I) 580 LSCS Faild 
Ind 
2.2 MSAF 
63. Chitra 29 Primi 36-37 32-33 0.9 0.8 <1 580     (I) 595 Vaginal  2.3 Good 
64. Thangam 28 G2A1 37-38 34-35 0.96 0.72 <1 586     (I) 600 Vaginal  2.2 Good 
65. Maheswari 29 G3P1L1A1 37-38 32-33 0.86 0.73 >1 550     (I) 575 Vaginal   2.4 MSAF 
66. Vijayalakshmi 32 G2P1L1 36-37 32-33 0.8 0.76 <1 566     (I) 550 LSCS Breech 2.4 Good  
67. Kumari 36 Primi 36-37 31-32 0.76 0.84 <1 320    (II) 335 LSCS Faild 
Ind 
2.1 MSAF 
68. Jayanthi 35 Primi 36-37 32-33 0.8 0.72 <1 335     (II) 340 LSCS Faild 
Ind 
2.1 Good  
69. Sathya 33 G2P1L1 36-37 31-32 0.9 0.72 >1 525      (I) 520 LSCS CTG 
NR 
2.1 MSAF 
70. Kala 32 G3A2 37-38 32-33 0.74 0.96 <1 540      (I) 550 LSCS Breech 2.1 Good  
71 Manjula 32 Primi 37-38 31-32 0.74 0.82 <1 475      (I) 480 LSCS Faild 
ind 
1.8 Low apg 
72 Rani 32 G3P2L2 37-38 30-31 0.88 0.78 >1 440      (I) 450 Vaginal  1.6 Low apg 
 
  
73 Sandhya 36 G2P1L1 36-37 31-32 0.76` 0.92 <1 446      (I) 450 LSCS Failed 
ind 
1.6 MSAF 
74 Poongodi 35 G2P1L0 36-37 30-31 0.92 0.86 >1 395     (II) 402 LSCS CTG 
NR 
1.2 NND 
75 Vanaja 33 Primi 37-38 30-31 0.78 0.88 <1 415      (I) 410 LSCS CTG 
NR 
1.4 MSAF 
76 Sarala 32 G2P1L1 37-38 30-31 0.74 0.88 <1 402     (I) 415 LSCS CTG 
NR 
1.75 LOW APG 
77 Indra 18 Primi 37-38 30-31 0.8 0.92 <1 202   (III) 195 Vaginal  1.3 NND 
78 Uma 20 Primi 37-38 31-32 0.96 1.2 <1 198   (III) 210 Vaginal  1.25 NND 
79 Devagi 25 Primi 37-38 32-33 0.82 0.76 >1 420      (I) 430 LSCS CTG 
NR 
1.5 MSAF 
80 Rajathi 24 Primi 36-37 33-34 0.84 0.76 >1 430      (I) 415 Lscs CTG 
NR 
1.7 MSAF 
81 Geetha 27 G2P1L1 37-38 34-35 0.82 0.78 >1 465      (I) 475 LSCS CTG 
NR 
1.7 GOOD 
82 Kanmani 28 G2A1 37-38 33-34 0.68 0.86 <1 342     (II) 335 Vaginal  1.5 MSAF 
83 Gandhimathi 29 G3P1L1A1 38-39 31-32 0.72 0.84 <1 410      (I) 420 LSCS CTG 
NR 
1.4 Low apg 
84 Suganthi 31 G2P1L1 37-38 34-35 0.82 0.76 >1 550      (I) 560 Lscs Failed 
ind 
2.2 Good 
85 Hema 31 G2P1L0 36-37 31-32 0.72 0.84 <1 340     (II) 350 Lscs CTG 
NR 
1.6 MSAF 
86 Amudha 30 Primi 37-38 33-34 0.82 0.76 >1 490      (I) 500 Lscs CTG 
NR 
1.8 GOOD 
87 Mahalakshmi 32 G3P1L1A1 37-38 34-35 0.78 0.86 <1 486      (I) 475 LSCS CTG 
NR 
1.9 GOOD 
88 Ambika 36 G2P1L1 37-38 34-35 0.86 0.75 >1 501      (I) 496 LSCS CTG 
NR 
1.9 LOW APG 
89 Akila 35 G2P1L1 37-38 32-33 0.84 0.78 >1 475      (I) 485 LSCS FAILED 
IND 
1.7 LOW APG 
90 Jesinda 34 G4P1L1A2 37-38 32-33 0.74 0.88 <1 480      (I) 470 LSCS FAILED 
IND 
1.8 GOOD 
91 Meera 33 Primi 37-38 34-35 0.68 0.82 <1 492     (I) 480 Lscs Failed 
ind 
1.9  Good 
92 Noorjahan 32 G4P2L2A1 38-39 34-35 0.74 0.68 >1 530      (I) 525 LSCS CTG 
NR 
2.2 GOOD 
  
93 Kala 33 G2P1L1 37-38 35-36 0.86 0.76 >1 565     (I) 579 LSCS Breech 2.4 Good 
94 Mary 34 G2P1L0 37-38 33-34 0.86 0.72 >1 440     (I) 450 LSCS CTG 
NR 
1.4 Low apg 
95 Mangai 32 Primi 38-39 30-31 0.64 0.88 <1 202   (III) 220 Vaginal  1.3 NND 
96 Bagyalakshmi 35 Primi 38-39 34-35 0.86 0.74 >1 630      (I) 640 LSCS CTG 
NR 
2.1 Good 
97 Pattu 34 G3P2L2 39-40 35-36 0.76 0.84 <! 646      (I) 630 LSCS CTG 
NR 
2.3 MSAF 
98 Sudha 35 G3P1L0A1 39-40 35-36 0.74 0.88 <1 675(I) 675 Vaginal  2.4 MSAF 
99 Priya 33 G2A1 38-39 36-37 0.84 0.72 >1 680(I) 690 Vaginal  2.5 Good 
100 Mariammal 35 Primi 39-40 35-36 0.82 0.76 >1 660(I) 675 Lscs CTG 
NR 
2.4 
GOOD 
 
 
S no NAME AGE OBST CODE GA(LMP) GA(USG) PV(USG) PV(DELI) DELIVERY BW OUTCOME 
1. Jeyanthi 18 Primi 34-35 35-36 536 546 Vaginal  2.3 LOW APGAR 
2. Nanthini 19 Primi 34-35 34-35 586 595 Vaginal  2.6 Good 
3. Meenakshi 21 Primi 35-36 34-35 590 580 LSCS 2.6 Good 
4. Anitha 22 Primi 35-36 36-37 575 586 LSCS 2.5 RESP 
DISTRESS 
5. Selvi 19 G2A1 34-35 35-36 568 550 Vaginal 2.4 Good 
6. Chellammal 20 Primi 34-35 34-35 545 530 Vaginal 2.5 Good 
7. Dhanalakshmi 23 G2P1L1 34-35 35-36 560 575 LSCS 2.6 Good 
8. Sudha  27 G2P1L1 35-36 36-37 572 585 Vaginal 2.7 Good 
9. Mallika  23 G3P1L1A1 36-37 35-36 570 585 lscs 2.9 Good 
10. Shanthi 25 Primi 35-36 36-37 555 570 Vaginal 2.6 Good 
11. Thilaka 24 G2A1 34-35 34-35 545 560 Vaginal  2.5 RESP 
DISTRESS 
12. Mala 25 G2P1L1 36-37 36-37 588 595 Vaginal  2.7 Good 
13. Saritha  26 Primi 35-36 36-37 590 585 LSCS 2.6 Good 
14. Jothi 24 Primi 34-35 35-36 540 555 Vaginal  2.7 Good 
15. Punitha  23 G2A1 34-35 34-35 552 565 lscs 2.8 Good 
16. Nagalakshmi 23 Primi 35-36 36-37 564 585 Vaginal  2.7 Good 
17. Mariammal 28 G3P2L0 34-35 35-36 515 525 lscs 2.4 LOW APGAR 
18. Umarani 30 Primi 35-36 34-35 546 555 Vaginal  2.7 Good 
19. Malathi 31 G3P2L2 36-37 35-36 546 585 Vaginal  2.9 Good 
  
20. Ambika  31 Primi 35-36 36-37 552 575 LSCS 2.8 Good 
21. Gomathi 29 G3P1L1A1 34-35 34-35 536 545 lscs 2.3 RESP 
DISTRESS 
22. Vennilla  28 G2P1L1 35-36 34-35 542 565 vaginal 2.4 Good 
23. Lakshmi 29 G2P1L1 35-36 36-37 570 580 LSCS 2.6 Good 
24. Shanthini 30 Primi 36-37 35-36 575 590 Vaginal  2.5 MSAF 
25. Jaya 31 G3P1L1A1 35-36 34-35 580 595 Vaginal  2.7 Good 
26. Raji 30 G3P2L0 34-35 33-34 530 555 Vaginal  2.6 Good 
27. Arifa 29 G2A1 35-36 35-36 545 560 LSCS 2.5 Good 
28. Vimala 32 Primi 35-36 36-37 555 565 Vaginal  2.4 Good 
29. Thara 36 G3P2L2 34-35 33-34 525 540 LSCS 2.3 Good 
30. Eswari 32 Primi 35-36 36-37 568 580 LSCS 2.7 Good 
31. Ponni 33 G4P1L1A2 36-37 35-36 580 575 LSCS 2.8 Good 
32. Bhavani 32 G2A1 34-35 34-35 536 545 Vaginal  2.5 Good 
33. Lakshmi 33 G2A1 33-34 34-35 538 545 LSCS 2.6 Good 
34. Malar 34 G3P2L1 35-36 36-37 542 555 Vaginal  2.9 Good 
35. Hema  32 Primi 34-35 35-36 520 530 Vaginal  2.2 RESP  
DISTRESS 
36. Nalini 33 G3P1L1A1 35-36 35-36 550 560 LSCS 2.6 Good 
37. Sangeetha  34 G2P1L1 36-37 36-37 568 580 LSCS 2.9 MSAF 
38. Saranya 36 G4P2L2A1 35-36 35-36 578 590 Vaginal  2.8 Good 
39. Santha  34 G2P1L0 34-35 35-36 525 540 LSCS 2.4 Good 
40. Vasantha 33 Primi 36-37 35-36 584 575 LSCS 2.5 Good  
41. Saheeba  32 G2P1L1 35-36 34-35 575 585 vaginal 2.6 Good 
42. Menaka 32 Primi 34-35 34-35 538 545 Vaginal  2.5 Good  
43. Kanchana  37 G5P1L0A3 36-37 36-37 574 590 LSCS 2.9 Good 
44. Sri Devi 38 G3A2 35-36 34-35 568 575 LSCS 2.7 Good 
45. Kamatchi 36 G2P1L1 34-35 34-35 555 560 Vaginal  2.7 Good  
46. Usha  32 G2A1 36-37 35-36 585 600 Vaginal  2.9 MSAF 
47. Josephin 33 G2P1L1 35-36 36-37 590 610 Vaginal  3.0 Good  
48. Deepa  33 Primi 34-35 35-36 530 545 LSCS 2.6 MSAF 
49. Manjula  33 G2P1L0 35-36 34-35 525 540 Vaginal  2.4 Good  
50. Priya  34 Primi 33-34 34-35 548 565 Vaginal  2.6 Good  
51. Lakshmi 18 Primi 36-37 36-37 605 610 LSCS 3.1 MSAF 
52. Kajalakshmi 19 Primi 36-37 37-38 595 580 LSCS 2.9 Good  
53. Vasantha 21 Primi 36-37 36-37 585 575 Vaginal  2.8 Good  
  
54. Shanthini 21 Primi 37-38 36-37 595 580 LSCS 2.9 Good  
55. Sharmila  23 G2A1 37-38 36-37 602 615 Vaginal  3.2 Good  
56. Lalitha  27 G2P1L1 37-38 37-37 610 620 Vaginal  3.1 Good  
57. Jaya 26 Primi 36-37 35-36 592 610 LSCS 3.0 Good  
58. Vanaja  25 G2P1L1 37-38 36-37 598 585 Vaginal  2.9 Good  
59. Patchiammal 28 G2P1L1 36-37 37-38 575 602 Vaginal  3.3 Good  
60. Sabana 28 G3P1L1A1 36-37 37-38 610 625 Vaginal 3.5 MSAF 
61. Rajalakshmi 31 Primi 36-37 35-36 600 590 Vaginal 2.9 MSAF 
62. Poornima  30 G2P1L1 36-37 35-36 582 590 Vaginal 2.8 Good  
63. Geetha  29 G3P1L1A1 35-36 36-37 594 594 LSCS 3.0 Good  
64. Ambarasi 32 G3A2 36-37 35-36 588 555 Vaginal 2.8 Good  
65. Padma 33 G3P1L0A1 36-37 37-38 576 592 Vaginal 3.2 Good  
66. Suguna 34 G3P2L2 37-38 36-37 594 602 Vaginal 3.0 Good  
67. Sarojini 33 Primi 37-38 38-39 598 615 LSCS 3.1 Good  
68. Ponni 32 Primi 36-37 37-38 570 590 Vaginal 3.0 MSAF 
69. Sarulatha 32 G2P1L1 36-37 35-36 575 590 Vaginal 2.9 Good  
70. Parimala 32 Primi 37-38 38-39 590 610 LSCS 3.2 MSAF 
71. Kumari 36 G3P1L1A1 36-37 37-38 575 600 vaginal 2.9 Good  
72. Sheela  34 G3P1L0 37-38 36-37 615 630 LSCS 3.4 Good  
73. Rani 35 G3A2 36-37 37-38 587 602 LSCS 3.1 Good  
74. Prabavathy 33 G3P2L1 37-38 36-37 588 595 Vaginal 3.2 Good  
75. Devi 18 Primi 37-38 38-39 625 633 Vaginal 3.1 Good  
76. Lakshmi 20 Primi 38-39 37-38 630 645 LSCS 3.2 Good  
77. Malarvizhi 20 G2A1 38-39 39-40 635 650 Vaginal 3.3 LOW APGAR 
78. Nagamani 23 Primi 37-38 38-39 604 615 Vaginal 3.1 Good  
79. Ramani 26 Primi 38-39 37-38 612 630 Vaginal 3.2 Good  
80. Jothi 27 G3A2 37-38 38-39 598 615 Vaginal 3.1 Good  
81. Pushpa 23 G2P1L1 37-38 37-38 630 645 LSCS 3.3 Good  
82. Anandhi 27 G3P1L1A1 38-39 38-39 640 625 Vaginal 3.1 Good  
83. Devi 28 Primi 38-39 37-38 625 610 LSCS 3.2 MSAF 
84. Esthar  30 Primi 37-38 37-38 595 615 Vaginal 2.9 Good  
85. Nagajothi 30 G2P1L1 38-39 38-39 610 600 Vaginal 3.0 Good  
86. Sobana 29 G2A1 37-38 36-37 605 620 Vaginal 3.1 MSAF 
87. Kokila  30 Primi 37-38 37-38 588 602 LSCS 2.8 Good  
88. Kousalya 32 G2A1 37-38 36-37 595 615 Vaginal 3.1 LOW APGAR 
89. Chinnamma  33 G3P2L2 38-39 37-38 625 610 Vaginal 3.2 Good  
  
90. Vanaja 32 G2P2L2 38-39 37-38 630 645 Vaginal 3.5 Good  
91. Bharathi 33 G4P1L1A1 37-38 38-39 610 625 LSCS 3.1 Good  
92. Soraja 34 G3A2 38-39 37-38 620 635 Vaginal  3.25 MSAF 
93. Dhakshyani 35 G2P1L1 37-38 36-37 605 630 Vaginal  3.1 Good  
94. Kalavathy 36 G3P1L1A1 38-39 38-39 626 645 Vaginal  3.25 Good  
95. Krishnaveni 36 G2P1L1 39-40 38-39 680 695 LSCS 3.6 Good  
96. Arthy 32 G2A1 39-40 39-40 676 695 Vaginal  3.4 Good  
97. Saratha 33 Primi 39-40 38-39 685 670 LSCS 3.6 Good  
98. Seetha  33 G2P1L1 39-40 39-40 690 685 LSCS 3.75 MSAF 
99. Thilakavathy 34 Primi 39-40 38-39 682 670 LSCS 3.2 Good 
100. Umamaheswari 35 G3A2 39-40 39-40 690 685 LSCS 3.3 Good  
 
 
  
 
ABBREVIATIONS: 
IUGR: Intrauterine growth restriction. 
CPR: cerebro placental ratio. 
LSCS: lower segment caesarean section. 
MSAF: meconium stained amniotic fluid. 
USG: Ultrasonogram. 
NND: Neonatal death. 
IUD: Intrauterine death. 
NICU: Neonatal intensive care unit. 
BPD: Biparietal diameter. 
HC: Head circumference. 
AC: Abdominal circumference. 
FL: Femur length. 
EFW: Estimated fetal weight 
  
  
 
